Pre-eclampsia or poor fetal growth

O15_PREEC_OR_FETGRO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O36.5 Hospital discharge: ICD-9 — 6565A\|6565B Cause of death: ICD-10 — O36.5 Cause of death: ICD-9 — 6565A\|6565B 2 out of 7 registries used, show all original rules.	5793
4. Check minimum number of events None	5793
5. Include endpoints O15_PRE_OR_ECLAMPSIA	15162
6. Filter based on genotype QC (FinnGen only)	14616

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	O15_PREEC_OR_FETGRO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	O15_PRE_OR_ECLAMPSIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O365
HD_ICD_9	6565A\|6565B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O365
COD_ICD_9	6565A\|6565B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-eclampsia or poor fetal growth based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	106315	106315	-
Only index persons	104055	104055	-
Unadjusted period prevalence (%)
Whole population	3.05	3.05	-
Only index persons	3.83	3.83	-
Median age at first event (years)
Whole population	-	28.82	-
Only index persons	-	28.80	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14616	14616	-
Unadjusted period prevalence (%)	5.18	5.18	-
Median age at first event (years)	29.18	29.18	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15162: Matched controls
151066

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8811

FHL

Cesarean section

3.0

317.6

1519

5355

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

+∞

307.7

498

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

863.9

307.7

2093

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

307.7

347

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

307.7

381

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.3

307.7

5389

29096

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

3.0

307.7

3551

13846

O14.1

ICD-10 Finland

Severe pre-eclampsia

12224.9

307.7

1146

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.9

307.7

3400

13898

C07AG01

ATC

labetalol; systemic

11.8

307.7

764

678

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

7.0

307.7

932

1406

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

307.7

2167

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

2.7

307.7

2088

8392

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.0

307.7

2254

8313

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

2311.5

307.7

5088

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

307.7

1353

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

307.7

464

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

7.8

307.7

3093

4810

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

10816.1

307.7

2718

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.0

307.7

4069

16482

205

Kela drug reimbursment

Chronic hypertension

2.5

299.8

2228

9826

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

+∞

298.5

286

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

2.0

291.6

4706

28155

66120

ICD-8 Finland

Occipital presentation

+∞

285.9

274

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.0

275.7

4316

25464

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.8

272.7

6615

44880

W84

ICPC

Pregnancy high risk

2.9

271.8

1412

5195

O41.0

ICD-10 Finland

Oligohydramnios

4.0

262.0

783

2039

SPAT1379

SPAT

Health check-up of pregnant person

2.0

255.8

3630

20619

O60

ICD-10 Finland

Preterm labour and delivery

3.4

247.3

951

2932

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

6.6

246.6

400

614

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

246.2

236

XMA22

NOMESCO Finland

General examination of pregnant woman

2.4

241.0

1933

8768

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

3.3

232.6

927

2920

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

224.7

5951

40747

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

3.5

220.9

783

2288

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

722.9

218.1

215

C09AA02

ATC

enalapril; systemic

2.3

214.2

1806

8345

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.5

212.0

1521

6542

O12.1

ICD-10 Finland

Gestational proteinuria

7.1

207.2

314

448

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

5.4

206.3

417

792

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.0

202.8

2564

13853

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.0

202.7

2654

14518

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

202.2

194

W78

ICPC

Pregnancy

1.8

200.2

4547

29578

SPAT1197

SPAT

Extensive health check-up of expecting family

1.8

200.1

3918

24401

ZXD05

NOMESCO Finland

Urgent procedure

1.7

194.1

5034

33920

C08CA05

ATC

nifedipine; systemic

3.1

187.7

847

2866

63799

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified

+∞

182.4

175

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

4.7

175.3

416

906

SPAT1380

SPAT

Postpartum check-up

1.8

173.5

2941

17422

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.6

170.4

570

1600

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.6

169.7

1061

4261

MAA00

NOMESCO Finland

Amniocentesis

3.1

168.5

734

2431

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.8

160.0

2941

17808

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.0

153.8

1908

10161

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.2

152.7

1360

6387

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.7

149.8

828

3122

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

8.8

147.5

185

211

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

2.1

145.6

1468

7237

O30.0

ICD-10 Finland

Twin pregnancy

3.4

143.4

541

1641

A10AC01

ATC

insulin (human); parenteral

2.4

135.8

1024

4473

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

131.4

2394

14369

C08CA01

ATC

amlodipine; oral

1.7

130.1

3283

21543

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

129.2

2360

14168

WX320

NOMESCO Finland

Spinalanesthesy

1.6

121.7

3234

21447

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.9

121.4

1587

8564

O16

ICD-10 Finland

Unspecified maternal hypertension

6.0

112.0

197

328

A10AE04

ATC

insulin glargine; parenteral

2.2

111.2

990

4630

A10BA02

ATC

metformin; oral

1.7

109.0

2659

17200

O32.1

ICD-10 Finland

Maternal care for breech presentation

2.0

108.5

1203

6117

SPAT1196

SPAT

Monitoring of normal pregnancy

1.8

108.2

1927

11437

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.7

107.9

2506

16001

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.6

107.8

2781

18239

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.7

105.6

593

2249

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.5

104.9

3863

27494

C07AB02

ATC

metoprolol; systemic

1.8

103.0

1813

10712

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

2.7

102.9

594

2284

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.8

100.8

539

1993

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

99.7

618

2461

SPAT1262

SPAT

Handing over of treatment supplies

1.8

98.6

1791

10671

A10AB05

ATC

insulin aspart; parenteral

2.2

97.2

862

4019

40199

ICD-8 Finland

Essential benign hypertension

6.3

90.9

154

247

T90

ICPC

Diabetes non-insulin dependent

1.7

90.0

2017

12705

W92

ICPC

Compl labour/ delivery livebirth

2.4

89.4

658

2835

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.0

87.9

391

1307

C09BA02

ATC

enalapril and diuretics; systemic

2.5

87.2

583

2405

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.6

85.3

2756

18934

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

84.5

1817

11308

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.2

83.9

766

3610

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

83.9

1752

10818

SPAT1263

SPAT

Sampling

1.4

82.5

6147

49502

O99.80

ICD-10 Finland

The fear of childbirth

1.8

81.9

1369

7938

63709

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD

+∞

79.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

77.1

5977

48276

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

75.3

546

2336

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

74.0

2241

15124

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.3

73.3

568

2500

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

4.5

72.6

180

406

A10AB01

ATC

insulin (human); parenteral

2.4

71.9

497

2081

W81

ICPC

Toxaemia of pregnancy

16.1

71.5

C07AB07

ATC

bisoprolol; oral

1.4

71.1

4397

34075

C02EA02, ,

ATC

3.7

69.8

220

593

66180

ICD-8 Finland

Occipital presentation

2.9

69.7

334

1164

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

69.6

1607

10156

B01AB05

ATC

enoxaparin; parenteral

1.4

68.6

3686

27843

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

68.3

671

3250

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

67.6

635

3023

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

67.5

320

1109

A10AE05

ATC

insulin detemir; parenteral

2.2

67.4

603

2817

C02CB01, ,

ATC

13.4

66.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

65.9

1864

12360

MAX99

NOMESCO Finland

Assistance to normal delivery

1.5

64.1

2437

17210

A10AB04

ATC

insulin lispro; parenteral

2.3

63.3

473

2050

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

62.6

455

1948

FM1NE

NOMESCO Finland

Ultrasound examination of fetal heart

3.8

62.5

191

504

OAA11, ,

SPAT

1.7

62.5

1327

8197

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

9.6

62.4

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

7.4

61.8

120

C09CA01

ATC

losartan; oral

1.5

61.3

2211

15434

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

4.7

60.7

142

306

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.3

60.5

6081

50514

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

2.9

58.9

289

1021

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.9

58.2

273

941

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

58.1

2124

14856

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

57.9

587

2876

O61.0

ICD-10 Finland

Failed medical induction of labour

2.7

57.1

303

1116

C08CA02

ATC

felodipine; oral

2.0

55.9

624

3166

T89

ICPC

Diabetes insulin dependent

2.1

55.5

521

2478

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

3.7

55.2

174

469

C03CA01

ATC

furosemide; systemic

1.5

54.9

1797

12269

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

54.8

2475

18011

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.1

54.8

152

374

A10AA02, ,

ATC

2.4

54.3

384

1624

W29

ICPC

Pregnancy symptom/complaint other

1.9

54.2

719

3868

A10BJ06

ATC

semaglutide; parenteral

2.0

54.2

575

2865

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.9

53.7

717

3865

C08CA13

ATC

lercanidipine; oral

1.7

53.3

1127

6944

O84.2

ICD-10 Finland

Multiple delivery, all by caesarean section

4.0

53.1

149

370

A10AA01, ,

ATC

2.4

52.8

371

1565

6563B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]

2.5

52.8

350

1438

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.5

52.7

2155

15383

C09DA01

ATC

losartan and diuretics; oral

1.8

52.3

902

5257

O36.3

ICD-10 Finland

Maternal care for signs of fetal hypoxia

3.6

51.8

175

495

SPAT1301

SPAT

No procedures

1.3

51.5

3879

30699

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

1.7

50.7

1040

6355

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

2.1

50.6

493

2380

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

49.6

1343

8782

A10BK03

ATC

empagliflozin; oral

1.8

49.6

778

4408

W85

ICPC

Gestational diabetes

1.7

48.2

1035

6398

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.6

47.7

1376

9126

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

7.0

47.5

103

H04AA01

ATC

glucagon; nasal, parenteral

2.3

47.4

365

1602

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

3.0

47.4

215

728

O02.1

ICD-10 Finland

Missed abortion

1.6

47.0

1244

8090

SPAT1310

SPAT

Counselling related to known health issue

1.3

46.2

4193

33986

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.7

46.0

820

4820

W90

ICPC

Uncompl labour/delivery livebirth

1.6

45.9

1219

7933

C02AC05

ATC

moxonidine; oral

2.4

45.7

310

1287

O12.0

ICD-10 Finland

Gestational oedema

3.5

45.5

154

436

C03AA03

ATC

hydrochlorothiazide; oral

1.8

45.2

674

3759

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.0

45.2

536

2777

ZXD00

NOMESCO Finland

Emergency procedure

2.0

44.9

466

2302

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

44.2

138

370

Z30.2

ICD-10 Finland

Sterilization

1.4

44.2

1855

13270

O20.0

ICD-10 Finland

Threatened abortion

1.9

44.2

584

3136

MAC98

NOMESCO Finland

Other induction of labor

4.5

44.1

106

234

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.7

44.1

239

891

OAA12, ,

SPAT

1.7

44.0

891

5420

OAA10, ,

SPAT

1.7

44.0

849

5099

Z39.1

ICD-10 Finland

Care and examination of lactating mother

1.9

43.6

550

2908

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.1

43.0

397

1877

Z35.4

ICD-10 Finland

Supervision of pregnancy with grand multiparity

2.8

42.8

211

748

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

1.8

42.8

669

3786

J01DB01

ATC

cefalexin; oral

1.3

42.7

12161

113526

E66.8

ICD-10 Finland

Other obesity

1.6

42.3

993

6269

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

2.1

42.0

393

1868

ZXE00

NOMESCO Finland

One hour or less

1.3

41.7

5323

44960

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.1

41.5

390

1857

A10BK01

ATC

dapagliflozin; oral

1.9

41.3

559

3025

C09AA05

ATC

ramipril; oral

1.5

41.0

1519

10600

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

3.2

40.9

165

522

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

2.4

40.8

272

1121

A10BB12

ATC

glimepiride; oral

2.3

40.5

303

1315

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

2.2

40.4

366

1718

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

40.1

1785

12895

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.3

40.0

302

1316

WX290

NOMESCO Finland

Other blockage of nerve

1.3

39.7

7549

66687

K85

ICPC

Elevated blood pressure

1.5

39.7

1348

9242

O43.8

ICD-10 Finland

Other placental disorders

8.2

39.6

O35.9

ICD-10 Finland

Maternal care for (suspected) fetal abnormality and damage, unspecified

2.5

39.5

256

1042

C09CA06

ATC

candesartan; oral

1.3

38.8

2790

21782

H3603, E103,

ICD-10 Finland

3.2

38.8

158

503

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.9

38.5

111

282

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

10.5

38.2

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

38.0

6035

52131

C09DA06

ATC

candesartan and diuretics; oral

1.7

38.0

659

3843

A12BA01

ATC

potassium chloride; oral

2.6

37.6

215

824

MA3AE

NOMESCO Finland

Combined first trimester screening

1.5

37.4

1292

8884

J01DA01

ATC

[U] cefalexin

1.2

37.2

8730

78703

WX892

NOMESCO Finland

Monitored bed care

1.7

37.2

635

3686

K02.1

ICD-10 Finland

Caries of dentine

1.2

37.0

9012

81561

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

1.9

36.8

469

2488

C07AG02

ATC

carvedilol; oral

2.1

36.7

354

1703

6563A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, RASKAUDEN AIKANA]

6.1

36.3

104

H3601, E103,

ICD-10 Finland

3.2

36.1

143

448

C10AA01

ATC

simvastatin; oral

1.3

35.9

2460

19043

A10AE06

ATC

insulin degludec; parenteral

2.0

35.9

394

1988

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

35.9

579

3307

A10BH01

ATC

sitagliptin; oral

1.7

35.4

653

3873

N02BE01

ATC

paracetamol; systemic, rectal

1.3

35.1

12812

121300

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.0

35.0

155

519

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

34.9

1846

13718

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

3.8

34.6

103

268

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

34.5

588

3411

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

1.6

34.4

955

6264

C10AA05

ATC

atorvastatin; oral

1.3

34.3

2987

23905

O15.0

ICD-10 Finland

Eclampsia in pregnancy

336.8

33.9

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

33.7

1129

7712

Z3232

NOMESCO Finland

Midwife

1.4

33.3

2009

15239

O36.4

ICD-10 Finland

Maternal care for intrauterine death

3.1

33.1

141

462

O28.3

ICD-10 Finland

Abnormal ultrasonic finding on antenatal screening of mother

2.6

32.7

186

711

H3600, E103,

ICD-10 Finland

2.7

32.6

175

650

OAA41, ,

SPAT

1.8

32.6

460

2523

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

32.6

746

4678

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

32.6

134

430

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

2.3

32.4

255

1131

SGA01

NOMESCO Finland

Emergency treatment

1.3

32.3

2446

19179

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

2.5

32.2

201

804

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

2.2

31.9

277

1280

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

31.8

571

3362

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

2.0

31.7

344

1728

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

31.7

5557

48227

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.8

31.6

249

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

2.6

31.5

187

731

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

31.3

1562

11481

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.5

31.3

194

774

O46.9

ICD-10 Finland

Antepartum haemorrhage, unspecified

1.9

31.2

390

2057

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

31.2

11140

104006

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.4

31.0

215

904

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

2.6

30.8

184

721

C10AX09

ATC

ezetimibe; oral

1.5

30.7

1069

7356

OAB50, ,

SPAT

1.8

30.5

507

2920

K86

ICPC

Hypertension uncomplicated

1.5

30.1

882

5854

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.1

30.1

290

1396

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.4

30.0

212

898

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

30.0

4462

37985

SPAT1153

SPAT

Removal of sutures

1.3

30.0

3235

26541

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.3

29.9

221

955

160

Kela drug reimbursment

exenatide

2.5

29.6

182

724

SFA20

NOMESCO Finland

Two-surface restoration

1.2

29.5

8829

80637

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

29.4

156

577

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

3.3

29.2

107

320

A02BC01

ATC

omeprazole; systemic

1.3

29.2

3177

26081

J01CA08

ATC

pivmecillinam; oral

1.2

29.0

7565

68107

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

29.0

513

3007

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.6

28.9

169

656

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.5

28.8

186

757

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

1.7

28.8

583

3544

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

1.8

28.8

475

2731

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

28.3

1029

7138

O84.0

ICD-10 Finland

Multiple delivery, all spontaneous

2.7

28.0

153

574

WX234

NOMESCO Finland

Paracervical blockade

1.6

28.0

700

4481

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

1.5

28.0

910

6171

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

28.0

130

448

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

27.9

250

1171

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

27.7

1119

7916

SFA10

NOMESCO Finland

One-surface restoration

1.2

27.7

8076

73350

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

27.3

3158

26085

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

27.2

10510

98003

Z37.2

ICD-10 Finland

Twins, both liveborn

3.6

27.1

253

6427A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]

+∞

27.0

SPAT1312

SPAT

General health counselling

1.2

26.9

4311

36898

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

2.0

26.7

312

1610

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

4.8

26.7

122

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.6

26.6

563

3462

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

26.6

3440

28764

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.1

26.4

257

1243

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.5

26.4

160

633

K04.0

ICD-10 Finland

Pulpitis

1.4

26.3

1436

10695

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

26.3

274

1359

A10BJ02

ATC

liraglutide; parenteral

1.9

26.2

332

1761

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

26.0

4262

36531

A10AD01

ATC

insulin (human); parenteral

2.4

25.9

172

710

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

25.9

7952

72360

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.3

25.9

2935

24165

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

25.6

4242

36391

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

25.6

6912

62136

O30.01

ICD-10 Finland

Twin pregnancy with a shared chorionic sac and a separate amniotic sac

4.6

25.4

131

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

2.3

25.2

193

849

O61.1

ICD-10 Finland

Failed instrumental induction of labour

3.4

25.1

261

O47.9

ICD-10 Finland

False labour, unspecified

1.8

24.9

381

2143

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.1

24.8

240

1158

W27

ICPC

Fear of complications of pregnancy

2.0

24.8

261

1300

O46.0

ICD-10 Finland

Antepartum haemorrhage with coagulation defect

8.4

24.7

W05

ICPC

Pregnancy vomiting/nausea

2.1

24.5

230

1097

O45.9

ICD-10 Finland

Premature separation of placenta, unspecified

3.3

24.4

266

65700

ICD-8 Finland

Occipital presentation

2.6

24.4

141

545

O03.4

ICD-10 Finland

Spontaneous abortion, Incomplete, without complication

1.7

24.2

465

2789

R51.80

ICD-10 Finland

Headache

1.3

24.2

2410

19518

SFA30

NOMESCO Finland

Three-surface restoration

1.2

24.1

5377

47404

C07FB02

ATC

metoprolol and felodipine; systemic

2.5

24.1

152

613

C01DA14

ATC

isosorbide mononitrate; oral

1.7

23.9

463

2783

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.0

23.9

107

362

C07AB08

ATC

celiprolol; oral

2.6

23.6

131

496

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

23.6

883

6153

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

23.6

4217

36388

C10AA07

ATC

rosuvastatin; oral

1.3

23.5

2759

22772

A08AB01

ATC

orlistat; oral

3.4

23.4

239

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

23.4

141

557

M04AA01

ATC

allopurinol; systemic

1.6

23.4

501

3092

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

1.6

23.3

621

4035

SPAT1097

SPAT

Recording of ECG

1.4

23.2

1169

8588

8221

FHL

Sterilization of the laparotomy pathway

1.8

23.1

376

2154

A10BJ05

ATC

dulaglutide; parenteral

2.2

23.0

195

894

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

23.0

189

856

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

22.8

4530

39459

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

4.0

22.6

161

SPAT1260

SPAT

Consultation of another employee

1.3

22.5

2017

16110

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

22.4

2597

21388

A10BX07

ATC

[U] liraglutide

2.8

22.4

113

408

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

22.4

711

4799

C03BA11

ATC

indapamide; oral

2.2

22.2

185

843

Z36.8

ICD-10 Finland

Other antenatal screening

1.7

22.1

438

2651

G47.3

ICD-10 Finland

Sleep apnoea

1.3

21.9

2019

16176

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.0

21.9

321

O20.8

ICD-10 Finland

Other haemorrhage in early pregnancy

2.4

21.9

150

629

O35.6

ICD-10 Finland

Maternal care for (suspected) damage to fetus by radiation

62.4

21.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

21.8

1132

8359

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

21.7

791

5484

C07AB03

ATC

atenolol; systemic

1.8

21.7

323

1803

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

21.7

955

6855

6542B

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, SYNNYTYKSEN AIKANA]

2.3

21.5

155

665

C08CA10

ATC

nilvadipine; oral

2.7

21.5

114

423

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.6

21.4

127

498

EBA00

NOMESCO Finland

Extraction of tooth

1.2

21.4

4496

39313

6510A

ICD-9 Finland

Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]

3.2

21.3

259

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

21.3

587

3844

C09CA03

ATC

valsartan; oral

1.5

21.1

616

4083

P01AB01

ATC

metronidazole; oral, rectal

1.2

21.1

5980

53648

O61.8

ICD-10 Finland

Other failed induction of labour

3.1

21.1

291

6542A

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, RASKAUDEN AIKANA]

3.1

21.0

271

WYA40

NOMESCO Finland

Assessment of oral health and treatment needs for family expecting first child

1.7

20.9

407

2450

SPAT1240

SPAT

Therapeutic discussion

1.3

20.9

1764

13969

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

20.8

5634

50337

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

20.7

1486

11514

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.1

20.6

280

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

1.9

20.5

239

1235

SPAT1254

SPAT

Administration of medicine

1.3

20.3

1326

10141

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

20.0

1202

9074

O14

ICD-10 Finland

Pre-eclampsia

23.3

19.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

19.7

3816

33059

R09

ICPC

Sinus symptom/complaint

1.3

19.6

1374

10611

6412B

ICD-9 Finland

Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]

4.3

19.5

113

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.3

19.4

150

664

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

19.4

133

559

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

19.0

1112

8364

C09DA03

ATC

valsartan and diuretics; oral

1.7

18.8

317

1836

M54.5

ICD-10 Finland

Low back pain

1.2

18.8

4953

44037

6426A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]

+∞

18.7

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.4

18.7

797

5690

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

18.6

786

5600

W03

ICPC

Antepartum bleeding

2.1

18.6

182

884

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.1

18.6

170

805

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

18.6

1348

10458

SPAT1283

SPAT

Restricted health certificate

1.2

18.5

3373

29033

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.5

18.4

584

3940

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

18.4

2905

24664

C07BB07

ATC

bisoprolol and thiazides; systemic

1.8

18.4

274

1533

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

18.4

2152

17710

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

18.3

412

2574

B01AC04

ATC

clopidogrel; oral

1.5

18.1

652

4512

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

1.6

18.0

411

2577

SPAT1192

SPAT

Gynaecological examination

1.2

17.9

2145

17689

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

17.8

200

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.3

17.7

133

582

O03.1

ICD-10 Finland

Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage

1.7

17.6

316

1864

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.0

17.6

184

917

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.5

17.6

168

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

17.5

5470

49229

N97.0

ICD-10 Finland

Female infertility associated with anovulation

1.6

17.4

433

2772

Y6099

ICD-8 Finland

Prenatal care and observation

1.5

17.4

488

3209

J01CA04

ATC

amoxicillin; systemic

1.2

17.3

12279

117732

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

17.3

355

2169

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.3

17.3

1782

14444

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.3

17.3

128

557

C08DB01

ATC

diltiazem; oral

1.9

17.2

220

1173

A46

ICD-10 Finland

Erysipelas

1.4

17.2

959

7156

MBA30

NOMESCO Finland

Manual removal of placenta from delivered uterus

1.7

17.1

330

1985

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

17.1

246

1362

66170, ,

ICD-8 Finland

3.4

17.1

171

T82

ICPC

Obesity

1.5

17.1

608

4199

C03DA01

ATC

spironolactone; oral

1.4

17.0

765

5513

O24.3

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified

6.4

17.0

Z94.0

ICD-10 Finland

Kidney transplant status

2.6

17.0

369

J01FF01

ATC

clindamycin; systemic

1.2

16.9

3149

27122

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.7

16.9

347

6423B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]

4.9

16.7

C09AA03

ATC

lisinopril; oral

1.8

16.7

255

1437

R80

ICD-10 Finland

Isolated proteinuria

2.8

16.7

282

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

16.7

1458

11585

O15.1

ICD-10 Finland

Eclampsia in labour

+∞

16.6

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

1.4

16.6

710

5070

MBA20

NOMESCO Finland

Expression of placenta

2.1

16.6

154

735

MBA04

NOMESCO Finland

Curettage of uterus after delivery

2.2

16.6

138

631

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.4

16.6

817

5980

6580A

ICD-9 Finland

Other problems associated with amniotic cavity and membranes, Oligohydramnios[OLIGOHYDRAMNION, RASKAUDEN AIKANA]

6.4

16.5

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.4

16.5

738

5313

O72.0

ICD-10 Finland

Third-stage haemorrhage

1.5

16.5

438

2847

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

16.5

970

7299

N02AX02

ATC

tramadol; systemic, rectal

1.2

16.5

4602

41003

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

16.4

1785

14551

A10BG03

ATC

pioglitazone; oral

2.1

16.4

153

731

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

16.3

117

502

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.7

16.3

280

1634

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

16.2

233

1290

B05DB

ATC

Hypertonic solutions

3.5

16.2

153

MBA96

NOMESCO Finland

Other removal of retained products of conception after delivery or abortion

1.6

16.2

379

2393

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

16.2

1385

10974

SGC10

NOMESCO Finland

Pulp capping

1.3

16.2

1276

10005

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

16.1

1361

10765

MA3AE, ,

SPAT

2.1

16.1

143

671

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

16.1

200

1059

O40

ICD-10 Finland

Polyhydramnios

1.8

16.0

235

1309

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

16.0

276

1612

XLD10

NOMESCO Finland

Gynaecological examination

2.1

16.0

146

693

C09DA07

ATC

telmisartan and diuretics; oral

1.7

15.9

284

1674

162

Kela drug reimbursment

liraglutide

2.5

15.8

371

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

15.7

1586

12823

B01AB10

ATC

tinzaparin; parenteral

1.3

15.6

1015

7749

Z49.2

ICD-10 Finland

Other dialysis

3.3

15.5

177

SPAT1255

SPAT

Intravenous administration of medicine

1.5

15.5

564

3912

A10BH05

ATC

linagliptin; oral

1.8

15.4

230

1289

B05DA

ATC

Isotonic solutions

3.3

15.4

173

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

15.4

216

1189

B01AB04

ATC

dalteparin; parenteral

1.5

15.3

510

3477

C07AA03

ATC

pindolol; systemic

3.2

15.3

189

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.5

15.2

559

3885

MAB10

NOMESCO Finland

External version

2.1

15.2

147

713

A10BX04

ATC

[U] exenatide

2.6

15.2

337

J01AA02

ATC

doxycycline; systemic

1.2

15.2

10483

99524

MA4AT

NOMESCO Finland

Chorion biopsy with ultrasound guidance

2.1

15.2

141

674

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

15.1

2468

20972

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

15.1

10327

97942

G02CB01

ATC

bromocriptine; systemic

1.6

15.1

310

1897

OAA70, ,

SPAT

1.6

15.1

322

1990

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

15.0

1031

7931

SPAT1200

SPAT

Guidance for breast-feeding and breast care

1.4

14.9

554

3857

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

14.9

122

554

O64.1

ICD-10 Finland

Obstructed labour due to breech presentation

1.7

14.9

293

1774

O84.8

ICD-10 Finland

Other multiple delivery

2.9

14.9

245

O45.8

ICD-10 Finland

Other premature separation of placenta

3.6

14.8

129

137

Kela drug reimbursment

Uraemia requiring dialysis

2.9

14.8

224

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

14.8

170

877

Z12

ICPC

Relationship problem with partner

1.6

14.8

313

1930

ACC51

NOMESCO Finland

Release of median nerve

1.3

14.8

871

6557

C02DE04, ,

ATC

3.0

14.7

204

Y4300

ICD-8 Finland

Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)

2.0

14.6

146

717

A11CC03

ATC

alfacalcidol; systemic

2.0

14.6

159

806

A10BX01

ATC

guar gum; oral

1.8

14.5

204

1123

A10AB06

ATC

insulin glulisine; parenteral

2.4

14.5

380

WX704

NOMESCO Finland

Intubation

1.3

14.5

878

6637

O73.0

ICD-10 Finland

Retained placenta without haemorrhage

1.9

14.5

173

905

6510B

ICD-9 Finland

Multiple gestation, Twin pregnancy[GEMINI, SYNNYTYKSEN AIKANA]

2.4

14.5

393

MA5AE, ,

SPAT

2.0

14.4

143

700

MBA40

NOMESCO Finland

Pharmacological evacuation of uterus after abortion

1.6

14.4

315

1958

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

14.4

178

942

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

14.3

258

1526

O72.1

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

4296

24206

2.07

320.68

4.8

3.7

24.21

7.10

mg/mmol

43.26

2982

14362

(3012516) Albumin [Mass/volume] in Urine

4134

23158

2.07

312.11

4.0

3.1

387.78

494.66

mg/l

0.86

2871

13615

(3009508) Creatinine [Moles/volume] in Urine

4584

28217

1.89

253.69

4.1

3.0

10.22

7.28

mmol/l

0.47

4039

24593

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1832

8932

2.19

189.44

3.9

3.8

239.05

231.07

u/l

0.81

1751

8447

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1806

9078

2.11

171.67

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1415

6657

2.23

158.43

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3027

18669

1.77

153.91

1.6

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

822

3134

2.71

145.46

3.0

1.7

1.16

1.45

g/l

16.00

739

2695

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1590

8200

2.04

139.44

1.8

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3854

26760

1.58

119.57

2.8

2.0

2142.20

2614.59

umol/l

0.50

3491

24001

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4832

35515

1.52

115.12

1.9

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4028

28662

1.54

110.54

1.8

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7697

64453

1.39

81.22

4.6

3.8

6.55

6.29

mmol/l

16.89

6872

58197

(3022217) INR in Platelet poor plasma by Coagulation assay

5176

40989

1.39

74.48

8.2

7.5

1.08

1.09

inr

0.56

1851

13137

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

745

3657

2.08

73.27

2.5

2.4

3.95

3.54

g/l

11.27

690

3460

(3037467) Urinalysis macro (dipstick) panel - Urine

10145

89621

1.39

73.03

4.6

4.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1922

12576

1.60

72.41

1.5

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

795

4046

2.01

70.78

2.3

2.1

5.34

5.23

umol/l

0.10

583

2911

(3031040) Bacteria [#/volume] in Urine by Automated count

9803

86530

1.36

68.07

4.6

3.9

755.95

1843.31

e6/l

2.56

101

933

(3029937) Albumin [Presence] in Urine by Test strip

4380

34168

1.39

67.30

4.2

3.6

0.00

estimate

0.01

1786

12759

(3023103) Potassium [Moles/volume] in Serum or Plasma

13409

125280

1.57

66.91

12.4

10.3

3.92

3.90

mmol/l

5.52

13093

121705

(3019550) Sodium [Moles/volume] in Serum or Plasma

13376

124936

1.57

66.44

12.3

10.2

139.42

139.62

mmol/l

22.03

13083

121682

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6095

50243

1.35

65.59

3.9

3.3

—

(3035350) Ketones [Presence] in Urine by Test strip

7572

64514

1.34

65.04

3.9

3.3

0.00

estimate

3.11

1865

13207

(3009261) Glucose [Presence] in Urine by Test strip

7640

65223

1.34

64.51

3.9

3.3

0.00

estimate

0.67

1776

12727

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7350

62455

1.33

63.77

2.6

2.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

7567

64709

1.33

62.17

5.1

4.4

0.00

estimate

0.07

1832

12831

(3020876) Protein [Mass/time] in 24 hour Urine

241

746

3.25

61.78

3.3

2.3

1.56

1.04

g/24h

2.39

138

345

(3026008) Bacteria identified in Urine by Culture

4660

37239

1.36

59.99

2.8

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4596

37171

1.33

53.02

3.2

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5087

41910

1.32

50.99

2.1

2.0

—

(40761536) Microorganisms panel - Urine sediment

1660

11644

1.47

43.82

3.9

3.3

—

(3037121) Protein [Mass/volume] in Urine

590

3194

1.87

43.54

3.2

2.8

0.52

0.24

g/l

6.68

286

1193

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3658

29288

1.32

43.46

2.1

1.7

1.26

0.88

mg/l

6.99

2789

21740

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

356

1608

2.23

43.22

2.6

2.3

136.43

58.25

ug/min

1.80

234

994

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1872

13497

1.44

42.67

2.6

2.2

8135.52

5909.56

u/l

2.15

899

5513

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4291

35186

1.30

42.64

2.8

2.6

29.75

48.61

ng/l

0.45

2106

15896

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2656

20347

1.36

42.30

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

456

2363

1.95

38.42

3.7

2.9

1.48

1.31

mg/l

4.94

432

2208

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1856

13660

1.40

37.30

2.2

2.0

28.76

29.17

2.24

1784

13210

(3024561) Albumin [Mass/volume] in Serum or Plasma

5292

45174

1.26

36.53

5.0

4.2

35.73

36.72

g/l

30.64

4960

42113

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6585

57884

1.24

34.10

5.2

5.3

9.41

9.60

umol/l

1.02

6203

54570

(3015736) pH of Urine

6005

52299

1.24

33.80

3.5

3.0

6.03

5.95

1.29

520

5566

(3003694) ABO and Rh group [Type] in Blood

5153

44143

1.25

33.71

1.9

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

493

2767

1.80

32.39

1.5

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

487

2742

1.80

31.67

1.7

1.6

7.53

7.57

mmol/l

0.22

472

2633

(3044640) Blood type and Crossmatch panel - Blood

4652

39614

1.25

31.57

2.1

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13948

134237

1.44

31.46

13.2

11.0

67.41

66.22

umol/l

5.95

13943

134183

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

487

2748

1.79

31.44

1.5

1.3

14.04

21.80

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

336

1694

2.00

30.70

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4263

36067

1.25

30.41

2.6

2.4

56.67

58.21

u/l

0.27

3992

33378

(3019150) Specific gravity of Urine by Refractometry

3332

27400

1.27

30.36

4.2

3.5

1.01

kg/l

0.16

568

4192

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14080

135862

1.46

30.12

10.2

8.7

25.02

23.88

u/l

7.30

13741

132004

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

457

2577

1.79

29.58

1.5

1.3

118.19

109.31

u/ml

0.55

123

603

(3036489) Thrombin time

728

4730

1.56

27.32

2.1

1.9

20.91

20.81

0.23

609

3927

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9771

90482

1.21

26.96

7.1

6.7

75.36

72.94

u/l

5.57

9278

85606

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3474

29186

1.24

25.54

2.3

2.1

2.81

2.71

mg/l

1.97

3041

25150

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1499

11345

1.35

24.75

6.6

4.9

1.06

1.04

mmol/l

1.80

1415

10650

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

610

3905

1.58

24.42

2.5

2.2

177.52

167.69

2.05

571

3678

(3007853) Bacteria identified in Skin by Aerobe culture

1762

13707

1.32

24.06

1.8

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

2674

21964

1.26

23.79

2.7

2.3

8.67

8.46

e6/l

0.23

2367

19461

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2406

19539

1.27

23.54

2.6

2.4

784.67

646.04

ng/l

1.10

1991

15970

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

631

4117

1.55

23.24

2.2

2.0

93.01

95.92

2.36

603

3916

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7762

70876

1.19

23.02

3.3

2.9

70.43

70.77

ug/l

0.06

7326

67291

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3447

29240

1.23

22.68

2.0

140.60

143.07

u/l

0.09

3260

27582

(3023368) Bacteria identified in Blood by Culture

2741

22782

1.24

21.72

3.8

3.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

888

6293

1.43

21.70

9.3

6.8

8.37

7.30

mmol/l

5.01

861

6056

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

359

2080

1.74

21.26

2.5

2.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11357

107623

1.20

20.76

5.5

4.3

39.30

37.50

mmol/mol

70.98

10764

101577

(3013512) EKG study

3189

27071

1.22

20.50

3.3

2.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1409

10855

1.32

20.46

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5749

51504

1.18

20.41

6.6

5.4

1.22

mmol/l

4.00

4836

43948

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11696

111220

1.21

20.24

4.9

4.4

14.41

14.36

pmol/l

1.67

10997

104267

(3004775) Volume in Urine collected for unspecified duration

121

478

2.53

20.11

2.7

2.2

630.42

616.09

0.16

377

(3016750) Collection duration of Urine

102

375

2.72

19.59

2.6

2.1

505.26

505.53

min

0.01

316

(3026782) Osmolality of Urine

2452

20353

1.24

19.43

2.9

2.5

519.47

516.55

mosm/kgh2o

0.24

2122

17345

(40761511) CBC panel - Blood by Automated count

14159

137770

1.36

19.19

12.3

9.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4749

42025

1.18

19.18

3.1

3.0

33.22

29.09

u/l

1.09

4510

40144

(3013707) Erythrocyte sedimentation rate by Westergren method

10050

94463

1.18

19.08

4.1

3.8

11.15

10.07

mm/h

15.45

9498

88800

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1267

9715

1.33

18.97

2.8

2.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13000

125143

1.25

18.95

5.6

5.1

1.68

1.97

mu/l

5.56

12350

118597

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

220

1136

1.94

18.94

1.2

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3409

29328

1.20

18.85

2.1

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5162

46050

1.18

18.84

5.9

4.8

1.22

mmol/l

1.74

4781

42342

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2688

22609

1.22

18.71

1.7

1.6

64472973.25

38949423.96

pmol/l

0.77

2294

19505

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1844

14964

1.26

17.75

2.7

2.2

2.48

g/l

0.07

1703

13867

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13452

130162

1.26

17.67

12.1

10.4

18.11

18.81

mg/l

1.87

10921

99755

(3002582) Erythrocytes [#/volume] in Urine

3641

31704

1.19

17.38

3.2

2.7

72.30

67.70

e6/l

0.07

2800

23493

(3025159) Blasts/100 leukocytes in Blood

1136

8688

1.33

17.29

4.2

4.1

0.09

0.46

2.32

262

1899

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

315

1870

1.69

17.16

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

1214

9408

1.31

16.80

4.1

4.0

0.97

0.92

0.22

341

2590

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12309

118131

1.20

16.78

10.4

9.0

90.51

90.68

ml/min/173m2

0.38

10329

96222

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1780

14475

1.26

16.77

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

416

2664

1.57

16.73

1.5

—

(3044889) 12 lead EKG panel

8403

78274

1.16

16.60

3.1

2.9

—

(3012544) pH of Venous blood

921

6871

1.36

16.55

4.8

3.6

7.38

—

(3021440) Promyelocytes/100 leukocytes in Blood

1167

9030

1.31

16.32

4.2

4.1

0.14

0.12

0.23

294

2221

(3002179) Metamyelocytes/100 leukocytes in Blood

1123

8652

1.32

16.21

3.8

0.66

0.68

0.09

299

2259

(3021589) Normoblasts [#/volume] in Blood

6135

55931

1.16

16.12

9.0

8.0

0.00

e9/l

0.09

5240

45906

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1658

13439

1.26

16.04

2.9

2.3

23.13

23.53

0.60

1411

11651

(3021447) Carbon dioxide [Partial pressure] in Venous blood

892

6656

1.36

16.01

4.9

3.6

5.85

5.83

kpa

0.22

864

6447

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1895

15620

1.24

15.76

3.3

3.1

0.85

0.82

mmol/l

4.78

1802

14696

(3009343) pH of Capillary blood

654

4651

1.42

15.69

3.2

2.8

7.41

7.42

0.57

101

639

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

297

1789

1.67

15.37

1.5

7.14

7.16

mmol/l

0.05

291

1758

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

659

4712

1.41

15.34

3.2

2.8

5.16

5.12

kpa

0.96

634

4473

(3002032) Base excess in Venous blood by calculation

882

6624

1.35

15.18

5.2

3.6

1.69

1.85

mmol/l

0.68

754

5626

(3023520) Reticulocytes [#/volume] in Blood

800

5937

1.36

14.88

2.6

2.5

73.40

71.83

e9/l

0.53

603

4283

(3022948) Iron [Moles/volume] in Serum or Plasma

2000

16687

1.22

14.75

2.7

2.2

13.81

14.37

umol/l

3.12

1871

15652

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

191

1026

1.87

14.71

1.3

—

(4146454) Self-monitoring of blood glucose

147

722

2.04

14.70

2.9

2.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

177

928

1.91

14.68

3.4

3.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

627

4491

1.41

14.47

3.2

2.7

1.50

mmol/l

0.01

459

3206

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

638

4601

1.40

14.15

1.2

—

(3016502) Oxygen saturation in Arterial blood

954

7326

1.32

14.08

7.3

7.2

96.33

96.32

0.02

909

7030

(3030467) Casts [#/volume] in Urine by Automated count

3304

28963

1.17

14.08

3.1

2.7

0.29

0.31

e6/l

0.40

2557

21206

(3002173) Hemoglobin [Mass/volume] in Arterial blood

912

6983

1.32

13.75

7.7

7.5

119.34

120.52

g/l

1.04

875

6782

(3026250) Tacrolimus [Mass/volume] in Blood

392

2.37

13.61

43.1

34.6

7.28

7.35

ug/l

0.13

362

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

732

5437

1.36

13.55

2.1

2.0

4.77

5.78

ug/l

1.02

651

4724

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

302

1897

1.60

13.28

1.1

76.43

5639.13

iu/ml

0.63

478

(3009542) Hematocrit [Volume Fraction] of Blood

14835

146108

1.54

13.21

18.7

15.6

39.49

39.80

4.94

14053

139472

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

167

891

1.88

13.19

1.3

1.1

25.80

10.97

u/ml

0.39

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

421

2856

1.48

13.04

1.2

—

(40768446) Kidney Pathology biopsy report

333

2.46

13.03

2.0

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

400

2686

1.50

13.02

1.3

1.2

271.88

264.13

u/ml

0.23

292

1773

(3000991) Gas panel - Venous blood

827

6294

1.33

13.02

9.8

7.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

718

5352

1.35

13.00

4.1

3.0

4.64

4.66

kpa

0.07

698

5167

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4067

36440

1.15

12.79

1.3

1.35

1.48

u/ml

0.37

1275

10548

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1039

8196

1.28

12.53

3.5

3.1

1.23

mmol/l

0.14

910

7154

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

153

810

1.89

12.41

1.5

1.4

1.57

1.49

nmol/l

0.40

140

727

(3007461) Platelets [#/volume] in Blood

14846

146310

1.53

12.34

18.7

15.7

267.37

268.80

e9/l

2.05

14651

143519

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1268

10262

1.25

12.34

1.4

—

(3010421) pH of Blood

344

2266

1.52

12.30

3.2

2.9

7.42

0.36

313

2104

(3019060) Gas panel - Arterial blood

627

4626

1.37

12.14

4.1

4.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

590

4311

1.38

12.14

4.2

3.1

126.59

129.82

g/l

3.11

573

4209

(3035941) MCH [Entitic mass]

14854

146422

1.53

12.14

18.6

15.6

29.94

30.03

8.01

14751

145069

(3008152) Bicarbonate [Moles/volume] in Arterial blood

625

4610

1.37

12.13

6.0

6.4

24.35

24.45

mmol/l

0.32

584

4365

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

132

671

1.97

12.09

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

14860

146503

1.53

12.03

18.8

15.7

132.39

132.99

g/l

8.81

14756

145160

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

724

5469

1.33

12.01

2.4

133.53

111.21

ng/l

0.89

638

4917

(3020630) Protein [Mass/volume] in Serum or Plasma

809

6214

1.31

11.94

2.3

66.69

67.27

g/l

1.28

747

5733

(3010813) Leukocytes [#/volume] in Blood

14856

146463

1.53

11.93

18.7

15.7

6.95

6.63

e9/l

65.53

14634

143397

(3027801) Oxygen [Partial pressure] in Arterial blood

1063

8460

1.27

11.93

7.3

6.7

13.33

13.62

kpa

0.88

1012

8086

(3027273) Bicarbonate [Moles/volume] in Venous blood

469

3305

1.43

11.93

3.6

2.9

25.24

25.36

mmol/l

0.32

453

3195

(3026361) Erythrocytes [#/volume] in Blood

14855

146452

1.52

11.92

18.7

15.6

4.44

4.45

e12/l

0.80

14637

143455

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1260

10231

1.25

11.90

1.5

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

12075

116479

1.16

11.90

14.2

12.4

14.55

14.86

1.53

11898

114606

(3014111) Lactate [Moles/volume] in Serum or Plasma

874

6793

1.30

11.82

7.9

6.5

1.25

mmol/l

0.05

861

6634

(3017143) Hepatitis C virus Ab [Presence] in Serum

2359

20373

1.18

11.80

1.7

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1265

10287

1.25

11.79

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1062

8465

1.27

11.77

7.3

6.7

5.00

5.04

kpa

0.72

1014

8095

(3024731) MCV [Entitic volume]

14853

146441

1.52

11.76

18.6

15.6

89.97

90.28

15.89

14749

145087

(3013290) Carbon dioxide [Partial pressure] in Blood

298

1927

1.55

11.62

3.1

2.9

4.91

5.00

kpa

1.52

288

1893

(3012501) Base excess in Blood by calculation

298

1927

1.55

11.62

3.1

2.9

2.20

2.38

mmol/l

0.61

175

1214

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1264

10294

1.24

11.62

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

697

5267

1.33

11.55

1.2

—

(3011985) Renin [Units/volume] in Plasma

253

1578

1.61

11.52

1.8

1.7

55.47

53.28

mu/l

0.06

224

1436

(3012565) Volume of 24 hour Urine

103

489

2.11

11.39

2.2

1.9

1878.32

1984.51

0.52

456

(1616796) Gas panel - Central venous blood

293

1897

1.55

11.37

3.4

2.7

—

(3027315) Oxygen [Partial pressure] in Blood

299

1945

1.54

11.36

3.2

3.0

9.14

8.97

kpa

0.76

289

1911

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

223

1355

1.65

11.29

1.9

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

2417

21008

1.17

11.14

1.4

554.59

569.14

titre

0.14

510

4361

(3003396) Base excess in Arterial blood by calculation

1057

8478

1.26

11.11

7.3

6.7

0.77

0.91

mmol/l

0.57

819

6583

(36304419) Bacteria [Presence] in Urine

3271

29098

1.15

11.11

3.0

2.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1068

8582

1.26

11.05

2.5

1.83

1.74

1.84

951

7635

(3015235) Bicarbonate [Moles/volume] in Capillary blood

290

1888

1.54

11.00

2.7

2.6

24.38

24.57

mmol/l

0.37

281

1837

(3042936) Bacteria identified in Isolate by Culture

1714

14501

1.20

10.78

2.0

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

245

1546

1.59

10.67

1.5

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

286

1871

1.53

10.63

3.6

2.6

0.84

0.86

nmol/l

0.23

234

1595

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1063

8577

1.25

10.62

2.8

2.3

70.35

76.03

ml/min/173m2

3.87

396

3194

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1449

1.60

10.55

1.5

1.4

868.45

401.79

pmol/l

0.56

210

1285

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12324

119319

1.16

10.48

4.0

3.6

5.78

5.60

mmol/l

40.16

11555

111884

(3018095) Leukocytes [#/volume] in Urine

4453

40582

1.13

10.41

3.7

3.2

91.35

76.29

e6/l

0.73

3078

26082

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

593

4456

1.34

10.24

2.0

2.1

40.02

24.46

iu/l

0.23

243

1843

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2949

26209

1.15

10.01

1.3

8.73

10.21

u/ml

0.64

1291

11030

(3028679) Herpes simplex virus Ab [Presence] in Serum

173

1022

1.69

9.82

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

455

3318

1.38

9.56

4.3

3.0

1.28

1.36

0.91

455

3293

(40760892) CBC W Ordered Manual Differential panel - Blood

6375

59538

1.12

9.56

6.3

6.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

251

2.43

9.54

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

900

7214

1.26

9.53

4.5

3.3

87.47

75.36

ng/l

3.25

783

6395

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1141

9391

1.23

9.50

1.5

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

185

1123

1.65

9.49

1.2

1.1

1.04

1.05

ratio

0.68

420

(3010937) Rubella virus Ab [Presence] in Serum

144

2.91

9.39

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3342

30069

1.14

9.39

1.7

1.6

1.40

1.33

mmol/l

3.71

2823

26134

(3022313) Gas panel - Capillary blood

440

3202

1.38

9.37

3.3

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1155

9535

1.22

9.34

1.5

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

877

7033

1.26

9.26

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

635

4893

1.31

9.22

6.3

6.2

24.40

24.65

mmol/l

1.10

626

4856

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

114

608

1.87

9.17

1.2

—

(3042733) HLA Ab [Presence] in Serum

281

2.31

9.13

5.4

4.9

—

(3018418) pH of Serum or Plasma

3417

30849

1.13

9.05

4.2

3.5

7.40

0.07

754

5805

(3019309) Folate [Moles/volume] in Red Blood Cells

1867

16156

1.17

8.97

1.8

1.7

1225.51

1178.17

nmol/l

1.34

1507

12636

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

141

810

1.74

8.90

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

355

2.14

8.87

2.3

3.5

2694.71

3161.41

mg/l

0.06

257

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2483

1.42

8.85

1.9

2.0

1.83

1.88

ug/l

0.03

312

2211

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

413

3006

1.38

8.81

3.9

4.5

1.67

1.74

0.51

382

2796

(40767503) Oxygen content in Capillary blood by calculation

259

1731

1.50

8.79

2.4

2.1

16.89

16.83

0.07

136

846

(4034850) Laboratory test

505

3795

1.34

8.77

9.0

7.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

181

1117

1.62

8.73

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

161

966

1.67

8.68

1.6

5.72

6.00

mmol/l

0.68

130

745

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4187

38364

1.12

8.60

1.7

—

(3045424) Erythrocytes [Presence] in Urine

311

2166

1.44

8.56

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1977

17246

1.16

8.56

2.9

338.06

282.62

ng/l

0.31

1088

9464

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

529

4019

1.32

8.53

8.9

8.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

323

2267

1.43

8.53

3.2

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1480

12615

1.19

8.51

2.0

2.1

361.52

377.64

nmol/l

2.70

1359

11647

(3022621) pH of Urine by Test strip

985

8085

1.23

8.43

3.1

2.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3046

27447

1.13

8.22

1.3

27.09

30.21

iu/ml

0.44

983

8955

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

144

854

1.69

8.14

1.9

1.7

102.10

101.11

0.14

121

761

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

408

3007

1.36

8.09

1.9

1.8

—

(3020891) Body temperature

398

2922

1.37

8.09

5.1

4.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

106

578

1.83

8.02

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

622

4877

1.28

7.95

2.0

2.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

236

1585

1.49

7.87

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

402

2974

1.36

7.80

3.9

4.6

0.92

0.03

372

2775

(3047181) Lactate [Moles/volume] in Blood

377

2774

1.36

7.58

3.9

4.8

1.14

1.23

mmol/l

2.16

328

2458

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1328

11329

1.18

7.56

3.6

3.4

4.55

4.53

pmol/l

0.29

1202

10201

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

3.03

7.51

10.1

10.4

4.41

4.98

mmol/l

0.93

102

(3011397) Hemoglobin [Presence] in Urine by Test strip

3235

29402

1.12

7.48

4.0

3.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1392

16038

0.85

7.39

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

523

1.83

7.32

2.0

2.1

1.36

nmol/l

0.01

436

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

864

7106

1.22

7.28

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

357

2623

1.36

7.27

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

137

2.69

7.26

5.5

4.1

20.63

37.13

ug/min

1.86

(3019225) pH of Specimen

1156

9789

1.19

7.17

3.9

3.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

108

614

1.76

7.16

1.7

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2522

22635

1.13

7.16

1.5

1.4

20.59

21.25

nmol/l

1.66

2224

19924

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

108

615

1.76

7.13

1.3

1.1

—

(3006315) Basophils [#/volume] in Blood

6693

63273

1.10

7.09

5.7

5.6

0.04

e9/l

1.09

5984

55860

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

577

4553

1.27

7.05

2.5

1.9

0.22

0.23

g/l

0.61

547

4334

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

110

633

1.74

7.01

1.1

95.98

96.49

0.06

265

(3034770) Mitochondria Ab [Titer] in Serum

454

3476

1.31

7.01

1.2

1.3

762.63

857.37

titre

0.18

133

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

948

11234

0.83

6.98

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

466

3583

1.31

6.97

6.5

4.1

23.76

24.21

mmol/l

2.67

456

3506

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1635

14277

1.16

6.94

1.2

157.67

151.52

iu/ml

0.25

681

5625

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

344

2533

1.36

6.93

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

322

2348

1.37

6.90

1.1

123.03

120.41

0.82

291

2129

(3014007) Fractional oxyhemoglobin in Arterial blood

576

4558

1.27

6.89

9.6

8.7

94.16

94.34

0.28

576

4538

(3001604) Monocytes [#/volume] in Blood

6675

63173

1.09

6.79

5.7

5.6

0.53

e9/l

1.11

5987

55903

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

589

4689

1.26

6.71

2.5

1.8

1.18

1.17

g/l

0.25

563

4473

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

149

2.54

6.69

5.2

6.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

187

1241

1.51

6.68

3.7

3.4

26.84

28.75

mu/l

0.33

177

1187

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

360

2689

1.34

6.62

1.6

1.5

6.43

6.70

mmol/l

1.69

333

2468

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

106

616

1.72

6.55

1.1

100.20

100.15

0.00

260

(3008116) Ketones [Moles/volume] in Urine by Test strip

193

2.33

6.55

1.5

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

2494

1.35

6.46

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

841

0.44

6.25

13.2

12.0

628.62

852.21

nmol/l

3.38

816

(3013115) Eosinophils [#/volume] in Blood

6906

65628

1.09

6.18

5.8

0.19

0.18

e9/l

6.10

6276

58860

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1015

8613

1.19

6.18

1.5

—

(3003181) Sodium [Moles/volume] in Urine

181

1215

1.49

6.16

1.5

1.4

63.41

64.83

mmol/l

0.18

147

937

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

380

2896

1.32

6.12

3.5

2.9

24.78

24.77

mmol/l

0.03

357

2703

(3006184) Hemoglobin [Mass/volume] in Capillary blood

278

2025

1.37

6.05

2.5

1.9

130.40

130.92

g/l

0.15

227

1464

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

4.09

6.04

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

128

800

1.60

6.02

3.1

2.7

150.61

45.60

mg/l

1.50

537

(3045414) Leukocytes [Presence] in Urine

722

5955

1.22

5.97

1.9

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.98

5.96

3.8

2.8

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

107

641

1.67

5.96

1.1

115.45

117.62

0.25

573

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

330

2475

1.34

5.96

1.3

1.2

4.67

3.88

u/ml

0.49

149

1033

(3021901) Oxygen saturation in Capillary blood

196

1347

1.46

5.94

2.6

2.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1493

13104

1.15

5.91

2.3

2.4

6.31

6.27

umol/l

0.04

1235

10967

(21494755) Public health laboratory ask at order entry panel

1687

18840

0.88

5.77

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

264

1928

1.37

5.68

3.5

0.36

0.37

u/ml

0.28

154

1070

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

129

820

1.57

5.67

1.1

1538.52

1470.48

miu/ml

0.29

129

820

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

620

1.66

5.65

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

6888

65607

1.08

5.64

5.7

5.6

1.99

1.97

e9/l

0.82

6318

59384

(3028626) Oxygen [Partial pressure] in Capillary blood

232

1664

1.40

5.58

2.6

2.4

8.81

8.72

kpa

0.30

226

1631

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.71

5.57

6.2

9.5

56.36

793.57

e6/l

0.92

(3006504) Eosinophils/100 leukocytes in Blood

6248

59297

1.08

5.56

5.7

2.84

2.77

1.98

5868

55793

(3019069) Monocytes/100 leukocytes in Blood

6278

59611

1.08

5.50

6.0

5.9

7.75

7.92

5.07

5915

56241

(3005719) IgG [Mass/volume] in Serum or Plasma

1090

9399

1.17

5.48

2.5

2.6

10.57

10.38

g/l

0.95

996

8628

(3030981) Hyaline casts [#/volume] in Urine by Automated count

608

4978

1.23

5.44

2.6

2.3

0.19

0.26

e6/l

1.20

574

4763

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

336

2564

1.31

5.41

1.3

1.2

3.26

3.09

u/ml

0.07

120

842

(3036525) Urea [Moles/time] in 24 hour Urine

6.17

5.36

1.5

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

514

4141

1.25

5.36

1.9

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1080

12367

0.86

5.30

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

167

1140

1.46

5.29

1.5

5.18

5.27

mmol/l

0.58

161

1087

(3039000) Anion gap in Blood

241

1763

1.37

5.18

4.7

6.0

11.28

11.12

mmol/l

0.35

212

1582

(3028026) IgM [Mass/volume] in Serum or Plasma

846

7181

1.18

5.18

1.7

1.8

1.36

1.33

g/l

0.20

779

6630

(3007566) Smooth muscle Ab [Titer] in Serum

443

3524

1.26

5.17

1.2

1.3

118.29

145.67

titre

0.28

344

(3018572) Chloride [Moles/volume] in Blood

241

1764

1.37

5.16

4.7

6.0

105.24

105.63

mmol/l

0.55

212

1583

(3009445) Proteinase 3 Ab [Units/volume] in Serum

533

4330

1.23

5.16

1.4

1.5

4.65

9.98

u/ml

2.27

108

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

598

4920

1.22

5.13

2.5

1.9

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

110

693

1.59

5.08

1.2

1.3

50.92

70.61

1.06

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

1292

1.42

5.04

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12127

118482

1.10

5.03

3.6

3.2

1.27

1.19

mmol/l

26.14

11479

111980

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12597

123307

1.11

5.01

4.0

3.6

1.51

1.57

mmol/l

55.53

11971

117114

(3036180) Methadone [Presence] in Urine

114

727

1.57

5.00

2.5

2.4

—

(3005033) Fetal Nuchal fold Thickness US

977

8417

1.17

4.99

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11214

109198

1.09

4.95

3.9

3.7

—

(40761535) Cells panel - Urine sediment

951

8187

1.17

4.91

4.1

3.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

150

1021

1.47

4.86

1.3

1.2

48.62

27.17

u/l

0.90

136

899

(40760888) Immunoglobulin light chains.free panel - Serum

201

1444

1.39

4.85

3.3

3.1

—

(3037756) Immunofixation for Serum or Plasma

178

1252

1.42

4.85

1.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

976

8431

1.16

4.83

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

129

853

1.51

4.82

1.5

1.7

119.68

123.46

0.27

120

798

(3004809) Band form neutrophils/100 leukocytes in Blood

189

1346

1.40

4.80

2.6

2.7

1.64

1.38

0.40

172

1229

(3033658) Prothrombin time (PT) actual/Normal

3042

28135

1.10

4.80

3.6

3.3

100.01

98.33

3.64

2903

27274

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

255

1907

1.34

4.78

3.2

3.1

30.09

36.18

mg/l

0.62

198

1527

(3034860) Kappa light chains.free [Mass/volume] in Serum

255

1910

1.34

4.74

3.2

3.1

33.84

68.87

mg/l

0.61

201

1528

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

233

1722

1.35

4.73

1.2

1.3

0.53

1.45

nmol/l

0.73

225

1667

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

465

3763

1.24

4.70

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

683

5743

1.19

4.69

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

230

2.00

4.68

1.1

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

209

1522

1.37

4.66

3.5

2.9

33.01

32.99

umol/l

0.00

197

1421

(40768797) Stomach Pathology biopsy report

1839

16604

1.12

4.65

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

232

1722

1.35

4.59

1.2

1.3

0.20

0.24

nmol/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

610

1.59

4.56

1.2

1.3

137.19

141.79

mmol/24h

0.30

610

(3024471) HLA-A [Type]

303

1.84

4.53

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

120

794

1.51

4.50

1.1

88.93

92.88

0.85

635

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12769

125213

1.10

4.47

4.3

3.9

2.85

2.91

mmol/l

12.93

12085

118540

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12652

124011

1.10

4.47

4.1

3.6

4.77

4.87

mmol/l

26.19

12025

118011

(3002030) Lymphocytes/100 leukocytes in Blood

6489

62026

1.07

4.46

5.8

5.6

29.38

29.83

3.17

6129

58681

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

245

1848

1.33

4.37

3.1

1.53

1.83

ratio

0.21

188

(3022096) Basophils/100 leukocytes in Blood

5990

57124

1.07

4.36

5.8

5.7

0.68

0.69

1.62

5604

53422

(3008898) HLA-B27 [Presence]

815

7013

1.17

4.27

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

227

1711

1.33

4.10

2.4

2.3

—

(3024932) HLA-DR beta [Type]

292

1.81

4.08

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

591

4973

1.19

4.07

3.2

2.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

236

1.90

4.04

1.4

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

621

1.54

4.04

1.5

133.17

131.68

nmol/l

0.13

621

(3018010) Neutrophils/100 leukocytes in Blood

6393

61218

1.07

4.04

5.6

5.5

56.78

56.30

2.99

6031

57871

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

110

2.36

4.02

2.2

3.7

0.81

1.08

mmol/l

0.40

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

123

840

1.46

4.00

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7547

72695

1.07

3.98

7.8

8.4

4.11

3.92

e9/l

11.70

6767

64174

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2264

20831

1.10

3.96

1.8

—

(3007463) Buprenorphine [Presence] in Urine

2.59

3.93

6.0

8.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

2046

1.29

3.91

6.7

5.1

1112.63

892.31

iu/ml

0.18

257

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

431

3538

1.22

3.88

1.6

474.09

291.81

titre

0.46

155

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1028

9064

1.14

3.87

2.3

2.2

0.22

0.23

g/l

1.13

965

8552

(3044009) aPTT.lupus sensitive (LA screen)

164

2.07

3.86

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

307

2431

1.26

3.84

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

207

1565

1.32

3.70

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4526

42926

1.07

3.70

1.9

1.8

98.79

100.09

pmol/l

1.06

2472

22372

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

764

1.46

3.70

1.7

1.8

1.79

2.43

u/field

0.88

395

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

219

1670

1.31

3.69

1.1

92.27

93.49

0.31

206

1569

(3016038) Potassium [Moles/volume] in Urine

469

1.60

3.69

1.3

28.16

33.81

mmol/l

1.97

406

(3017732) Neutrophils [#/volume] in Blood

1078

9566

1.13

3.68

2.1

2.4

4.88

4.41

e9/l

0.58

932

8207

(3019174) dRVVT (LA screen)

162

2.03

3.60

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

766

6662

1.15

3.54

1.3

0.52

1.08

u/ml

1.96

550

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

202

1533

1.32

3.54

2.9

2.4

215.57

11778.20

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

369

3015

1.22

3.51

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

189

2470

0.76

3.50

1.0

0.24

0.30

u/ml

0.11

599

(3003338) MCHC [Mass/volume]

11531

116833

0.93

3.48

15.4

13.1

331.97

331.70

g/l

2.59

11460

116026

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

407

1.62

3.46

1.2

1.3

30.67

19.06

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

349

2842

1.23

3.44

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1757

16088

1.10

3.41

1.7

—

(36660697) Celiac disease serology panel - Serum

1418

12856

1.11

3.35

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

586

5018

1.17

3.35

1.1

7.86

4.24

u/ml

0.53

799

(3007164) IgA [Mass/volume] in Serum or Plasma

3239

30466

1.08

3.30

1.4

2.17

2.12

g/l

1.47

2069

19256

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

319

2589

1.23

3.27

1.3

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.92

3.27

1.0

354.00

170.35

pmol/l

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.92

3.27

1.3

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.15

3.18

6.0

5.5

347.50

410.71

umol/l

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

5.32

3.18

7.4

3.7

1.76

1.42

g/l

—

(3004451) EKG impression Narrative

280

1.71

3.13

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

1563

1.29

3.12

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

372

1.61

3.11

2.5

2.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

284

2293

1.24

3.08

1.2

—

(3011648) Oxygen content in Venous blood

621

1.46

3.07

3.5

2.3

10.96

11.16

0.20

621

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

104

728

1.43

3.07

1.4

1.7

2.25

9.98

nmol/l

0.54

603

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

194

1499

1.29

3.04

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

232

2885

0.80

2.94

1.1

4.04

5.03

u/ml

0.42

1162

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

127

2.04

2.93

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2966

27923

1.07

2.93

2.0

—

(3022689) Creatine [Moles/volume] in Urine

286

1.67

2.92

1.7

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

145

1083

1.34

2.91

1.2

52.17

46.48

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

303

3646

0.82

2.82

1.1

3.62

5.14

u/ml

1.10

148

1829

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

139

1038

1.34

2.81

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

144

1082

1.33

2.79

1.3

1.2

64.40

59.06

u/ml

—

(3006598) pH of Arterial cord blood

2.76

2.79

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

399

1.55

2.79

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

407

1.54

2.79

1.3

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

139

1040

1.33

2.78

1.2

2.32

9.00

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4481

42823

1.06

2.76

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

242

1948

1.24

2.74

3.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

307

1.62

2.74

2.0

25.50

71.93

ug/min

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

289

3482

0.82

2.74

1.1

1.85

u/ml

0.00

133

1654

(3017354) Segmented neutrophils/100 leukocytes in Blood

113

822

1.37

2.71

2.4

2.7

56.77

55.22

0.33

104

706

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

204

1613

1.26

2.71

1.2

1.1

—

(3000012) Reticulocyte production index

117

857

1.36

2.69

2.1

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.98

2.69

6.5

2.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

233

1.71

2.67

1.1

1.2

0.51

82.82

mg/l

1.90

169

(3025468) Yersinia sp identified in Specimen by Organism specific culture

185

1448

1.28

2.67

1.2

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

1013

1.33

2.66

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

185

1449

1.28

2.66

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

228

1831

1.24

2.65

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

229

2812

0.81

2.63

3.7

3.6

39.24

31.96

u/ml

0.26

221

2710

(3008401) Mugwort IgE Ab [Units/volume] in Serum

287

3445

0.83

2.63

1.1

1.36

1.10

u/ml

0.12

107

1375

(3005988) Vibrio sp identified in Specimen by Organism specific culture

185

1452

1.27

2.62

1.2

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

350

1.57

2.62

1.4

1.5

17.39

17.59

umol/l

0.13

310

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

2765

1.20

2.61

2.3

2.0

7.26

7.27

g/l

0.03

307

2545

(3048689) Calprotectin [Mass/mass] in Stool

2159

20177

1.08

2.61

2.5

2.3

103.36

101.66

ug/g

0.09

1735

15708

(37021550) Renin [Units/volume] in Plasma --upright

235

1.70

2.60

1.4

1.3

37.64

77.78

mu/l

2.11

188

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

187

1472

1.27

2.59

1.3

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

113

2.03

2.58

1.0

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2761

1.20

2.57

2.3

2.0

3.47

3.56

g/l

0.77

307

2544

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2761

1.20

2.57

2.3

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1396

12826

1.09

2.56

4.1

3.6

32.54

32.81

0.43

1097

9495

(3022670) pH of Venous cord blood

2.85

2.53

1.2

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

253

1.66

2.50

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

198

1578

1.25

2.49

5.6

3.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

253

3046

0.82

2.42

1.0

1.1

3.20

4.73

u/ml

1.17

118

1386

(3024522) Salmonella sp identified in Specimen by Organism specific culture

185

1469

1.26

2.41

1.2

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

203

1.72

2.40

1.1

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

241

1971

1.22

2.40

1.8

1.5

0.60

1.67

titre

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

124

1.93

2.37

19.3

8.5

—

(3047189) Immunofixation for 24 hour Urine

265

1.62

2.36

1.6

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

151

1174

1.28

2.35

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5717

55199

1.05

2.34

2.5

2.3

74.88

1669.61

nmol/l

0.50

5331

51449

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2660

1.19

2.33

2.3

2.0

2.82

2.84

g/l

0.16

293

2442

(3033923) Metanephrine [Moles/time] in 24 hour Urine

228

1.66

2.32

1.1

0.59

0.61

umol/24h

0.11

112

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.20

2.29

5.8

4.3

0.19

0.17

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1842

17201

1.08

2.29

2.7

2.3

1.19

1.38

e6/l

0.46

1097

9167

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

258

2141

1.20

2.24

1.4

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.27

2.22

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

131

1009

1.30

2.21

2.4

5.6

7.59

7.05

mmol/l

0.55

102

813

(3028707) Methadone [Presence] in Urine by Screen method

399

3442

1.16

2.20

3.6

2.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

496

4348

1.14

2.18

1.7

1.6

0.18

5.34

iu/ml

0.69

819

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

151

1187

1.27

2.18

2.0

25.22

23.10

mg/l

0.22

322

(3017704) Immunofixation for Urine

319

1.53

2.17

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3965

37998

1.05

2.14

2.9

3.1

2.34

2.35

mmol/l

2.38

3599

34232

(3020961) Endomysium IgA Ab [Titer] in Serum

920

8370

1.10

2.13

1.1

310.00

188.67

titre

0.36

214

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

1.80

2.11

2.4

2.2

7.72

6.70

mmol/l

0.58

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

293

2478

1.18

2.09

2.0

2.1

189.92

454.05

ug/l

1.86

264

2202

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

353

4069

0.86

2.08

1.1

2.87

2.01

u/ml

0.67

155

1964

(3014051) Protein [Presence] in Urine by Test strip

379

3277

1.16

2.05

2.6

2.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

221

1.62

2.05

1.1

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

221

1826

1.21

2.04

1.4

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

101

760

1.33

2.04

1.4

1.5

5.42

5.34

u/l

0.08

630

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

269

1.56

2.02

1.7

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

248

2075

1.19

2.01

1.4

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

360

3107

1.16

2.00

1.3

1.2

29.90

13.82

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

189

1541

1.22

2.00

1.1

1.45

1.48

g/l

0.50

175

1400

(3006462) Nitrate [Presence] in Urine

634

1.35

2.00

2.8

2.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

310

1.51

1.99

2.2

2.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

644

1.35

1.97

1.6

1008500.00

1754819.30

iu/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

229

0.43

1.96

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

113

870

1.30

1.95

1.7

1.6

42.07

39.21

0.30

521

(3041806) Other cells [#/volume] in Blood by Manual count

992

0.73

1.94

1.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

304

2598

1.17

1.94

1.6

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

647

1.34

1.92

3.7

3.1

0.75

0.81

nmol/l

0.84

488

(3034614) HLA Ag [Interpretation]

2.72

1.92

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

164

1.70

1.91

4.4

5.3

—

(3044927) Protein electrophoresis panel - Urine

605

1.35

1.91

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1311

12182

1.08

1.89

6.0

4.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

373

3245

1.15

1.88

1.3

1.08

4.17

u/ml

2.32

265

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

235

1.57

1.86

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

258

2184

1.18

1.86

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

609

1.34

1.84

1.6

1.8

130.86

140.35

0.61

563

(3052851) Hemolysis interference index of Serum or Plasma

361

3140

1.15

1.84

2.6

2.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.38

1.83

1.5

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

2567

1.16

1.82

2.0

10.11

10.00

g/l

0.16

275

2337

(3015350) Toxocara sp Ab [Presence] in Serum

4.15

1.81

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

611

1.34

1.81

1.5

1.6

2.56

1.93

u/field

0.19

441

(3035637) Corticotropin [Mass/volume] in Plasma

188

1552

1.21

1.80

1.4

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

254

1.53

1.78

1.3

1.2

441.21

401.76

pmol/l

0.16

194

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

368

1.44

1.77

1.2

1.1

95.82

87.57

0.58

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

247

2095

1.18

1.76

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2374

1.17

1.74

2.2

2.1

0.44

0.50

g/l

0.21

247

2104

(3019420) Tryptase [Mass/volume] in Serum or Plasma

117

922

1.27

1.73

1.4

6.60

7.12

ug/l

0.25

104

823

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

600

1.33

1.71

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.28

1.69

5.4

3.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

533

1.35

1.68

1.4

22.25

18.88

u/ml

0.34

101

(3022145) Colonoscopy Study observation

1410

13202

1.07

1.68

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.99

1.67

6.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

267

1.49

1.65

1.5

1.6

0.41

ug/l

0.01

190

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.79

1.64

5.4

2.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

701

6390

1.10

1.63

1.1

1.44

9.11

u/ml

0.87

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3262

31318

1.05

1.62

2.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.56

1.61

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

368

1.41

1.60

1.1

69.63

73.26

—

(3048879) Bone marrow aspiration report

158

1.64

1.59

1.2

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

845

9106

0.92

1.59

3.3

3.6

15.47

20.70

ug/l

0.30

607

6674

(4281824) Cell count and differential, peritoneal fluid

145

1755

0.82

1.59

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

254

2184

1.16

1.56

2.1

2.0

0.00

0.01

g/l

1.84

237

2003

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

167

1.61

1.55

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

738

0.73

1.55

1.5

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

402

4487

0.89

1.54

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.97

1.52

1.1

7.93

11.93

u/l

0.44

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

858

9219

0.92

1.52

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

3.32

1.51

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

105

835

1.25

1.48

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

268

2325

1.15

1.48

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

477

1.34

1.47

1.6

1.5

7.00

4.35

0.49

101

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1383

13010

1.07

1.46

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

119

962

1.23

1.46

1.1

291.14

305.09

mg/l

1.32

109

852

(3001964) Herpes simplex virus Ag [Presence] in Specimen

426

0.65

1.45

1.6

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

424

3795

1.12

1.44

10.7

8.9

23.83

24.21

mmol/l

1.62

418

3707

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

104

830

1.25

1.43

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

117

1.70

1.42

22.4

8.6

—

(3000492) Spirometry study

1229

12999

0.94

1.42

1.4

—

(3034426) Prothrombin time (PT)

497

1.32

1.42

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

420

1.35

1.41

19.8

26.6

113.07

114.71

ug/l

0.05

345

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

743

1.26

1.41

3.0

2.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

515

1.32

1.41

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

983

9153

1.07

1.41

1.5

1.6

286.54

317.58

mu/l

1.94

850

8143

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

164

1.58

1.40

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

133

1094

1.21

1.39

1.4

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.19

1.36

1.2

1.1

280.78

263.19

u/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.60

1.36

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

1.34

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

134

1109

1.21

1.33

3.3

2.9

5.30

9.05

nmol/l

0.32

129

1059

(3005082) Progesterone [Moles/volume] in Serum or Plasma

241

2095

1.15

1.33

1.3

1.4

29.37

32.35

nmol/l

1.00

219

1931

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

652

1.27

1.33

1.1

146.27

155.56

iu/ml

0.21

647

(3023323) Follitropin [Units/volume] in Serum or Plasma

1514

14339

1.06

1.30

1.3

25.75

26.65

iu/l

0.53

1346

12490

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

337

3002

1.12

1.28

1.2

1.3

29.71

e6/l

0.00

272

2320

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

104

843

1.23

1.28

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

108

879

1.23

1.28

6.3

6.5

11.56

11.26

mg/l

0.30

102

818

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

454

1.32

1.28

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

504

4588

1.10

1.27

1.3

31.37

35.33

u/ml

0.12

332

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

511

4655

1.10

1.27

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

498

1.30

1.27

1.2

1.3

—

603.85

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

490

1.30

1.26

1.8

2.2

1.08

1.30

ug/l

0.63

465

(3017509) Phencyclidine [Presence] in Urine

218

1.46

1.25

2.1

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

361

1.35

1.25

2.5

3.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

552

1.28

1.25

2.3

2.4

169.73

146.24

au/ml

0.17

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

489

4451

1.10

1.24

1.5

1.4

0.49

0.48

nmol/l

0.05

398

3555

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

126

1046

1.20

1.23

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

149

1256

1.18

1.23

1.3

1.2

55.64

59.00

u/l

0.46

139

1146

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

380

1.34

1.22

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

380

1.34

1.22

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1138

10714

1.06

1.21

1.3

159.93

186.03

u/ml

0.59

1056

9929

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

336

3007

1.12

1.20

1.3

1.4

496.23

2562.35

e6/l

0.99

291

2435

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

181

1556

1.16

1.19

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

221

1.44

1.18

1.3

—

(40758292) HTLV I+II Ab panel - Serum

186

0.54

1.17

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

561

5158

1.09

1.16

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

894

9475

0.94

1.15

1.5

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

1.15

0.0

1.1

—

253.47

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

223

1.43

1.14

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

333

1.35

1.14

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

333

1.35

1.14

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.80

1.13

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.84

1.12

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

482

1.28

1.12

1.2

1.3

72.50

54.77

titre

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

571

0.75

1.10

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

450

4109

1.09

1.10

1.3

9.94

6.53

u/ml

0.28

457

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

634

1.24

1.10

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

599

1.25

1.09

2.8

7.04

8.35

mg/l

1.14

465

(3006922) Hepatitis E virus Ab [Presence] in Serum

111

924

1.20

1.09

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

136

0.51

1.09

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

272

3028

0.89

1.09

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

181

1570

1.15

1.08

1.4

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

129

1090

1.18

1.08

1.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

181

1571

1.15

1.07

1.4

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

112

1327

0.84

1.07

1.0

—

(3008295) Osmolality of Serum or Plasma

112

935

1.19

1.07

1.8

1.6

280.44

280.98

mosm/kgh2o

0.10

731

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

129

1091

1.18

1.07

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

165

1424

1.16

1.06

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

453

0.73

1.06

1.3

1.4

11.85

11.37

u/l

0.21

437

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

141

1205

1.17

1.04

1.7

1.6

49.20

48.51

0.07

745

(40768441) Liver Pathology biopsy report

107

893

1.20

1.04

1.4

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

559

1.25

1.03

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

568

1.25

1.03

2.0

1.9

8.50

9.47

mg/l

0.85

457

(3002523) Influenza virus A Ag [Presence] in Specimen

273

3027

0.90

1.03

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

471

1.27

1.02

2.9

2.5

45.79

49.03

umol/l

0.45

410

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

1124

1.17

1.02

1.5

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

332

3002

1.10

1.02

1.2

3.68

3.58

mmol/l

1.12

309

2816

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

831

1.20

1.02

1.9

1.5

1.01

1.32

promille

1.35

630

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

388

4223

0.91

1.02

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

137

1171

1.17

1.01

1.3

1.2

0.35

1.46

u/ml

5.11

615

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

654

6966

0.93

1.01

1.6

4.01

3.81

mg/l

0.31

496

4950

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

740

0.79

1.00

1.2

—

(40768793) Breast Pathology biopsy report

395

4292

0.91

1.00

1.3

—

(3024263) Appearance of Synovial fluid

455

1.27

1.00

1.5

—

(1761868) Lipid panel - Serum or Plasma

5252

51326

1.03

0.99

2.5

2.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.70

0.97

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

132

1130

1.17

0.97

1.1

1.2

—

(21494434) Karyotype in Bone marrow

556

1.24

0.96

1.2

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.3

—

210.20

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1160

0.84

0.96

1.1

1.0

0.13

0.41

u/ml

3.62

247

(40765096) Chromosome analysis panel by Banding

190

1.42

0.94

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

454

4185

1.08

0.93

1.3

8.54

9.87

u/ml

0.14

702

(3000093) Morphology [Interpretation] in Blood Narrative

778

1.19

0.91

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

243

1.35

0.90

2.1

2.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

264

2905

0.90

3.3

3.4

482.25

414.12

u/ml

0.10

224

2469

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

454

1.25

0.89

1.1

56.51

55.79

u/ml

0.02

445

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

481

1.24

0.89

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

958

10034

0.95

0.88

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

178

1570

1.13

0.88

2.8

3.3

137.74

631.99

u/ml

1.57

161

1424

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

491

1.24

0.88

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

563

1.22

0.88

1.5

1.4

13.81

13.76

pmol/l

0.03

479

(3014765) Yersinia sp identified in Stool by Organism specific culture

396

4264

0.92

0.85

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

397

4272

0.92

0.84

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.93

0.84

1.0

2.3

3.11

2.03

mu/l

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

290

1.31

0.84

1.0

65.10

75.97

ug/l

1.37

255

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

612

1.21

0.83

1.1

1.2

113.37

110.85

0.35

545

(3014271) Vancomycin [Susceptibility]

221

1.35

0.83

2.3

2.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

112

1.51

0.83

1.1

1.49

1.46

umol/24h

0.08

112

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

342

0.73

0.83

1.5

2.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

157

1381

1.13

0.83

1.3

5.19

5.57

umol/l

0.78

144

1280

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

370

1.27

0.83

1.8

2.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

159

1402

1.13

0.81

1.4

6.73

6.58

g/l

0.22

109

990

(3003157) Bacteria [#/volume] in Mother's milk

1.69

0.81

6.3

6.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

256

2320

1.10

0.81

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

310

2835

1.09

0.80

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

772

0.83

0.80

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

743

1.18

0.80

2.7

1.9

105.11

105.89

mmol/l

0.94

738

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1671

16084

1.04

0.80

2.8

2.5

5.83

4.94

e6/l

1.38

920

8118

(3010838) Calcium [Moles/time] in 24 hour Urine

259

2350

1.10

0.80

2.0

5.22

5.36

mmol/24h

0.28

228

2142

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.60

0.80

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

134

1520

0.88

0.80

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

142

1604

0.88

0.79

4.4

5.5

363.60

379.33

umol/l

0.67

120

1393

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

155

1.41

0.79

1.1

1.5

92.03

49.68

ng/l

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

5.3

—

5.74

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

618

5807

1.06

0.78

1.6

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

445

1.23

0.78

1.9

1.6

70.29

141.83

au/ml

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

663

1.19

0.78

1.2

0.31

0.30

g/l

0.61

534

(3020911) Cortisol [Moles/time] in 24 hour Urine

609

1.20

0.77

1.2

1.4

70.68

144.44

nmol/24h

1.16

609

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1638

16881

0.96

0.77

1.8

1.6

1.38

1.32

3.50

1455

15206

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.62

0.77

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

109

941

1.16

0.77

2.6

2.2

—

(3000285) Sodium [Moles/volume] in Blood

1.55

0.77

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

158

1400

1.13

0.76

1.4

3.12

2.96

g/l

0.51

108

990

(3051387) C reactive protein [Mass/volume] in Capillary blood

255

2319

1.10

0.76

3.8

3.2

20.69

23.33

mg/l

0.67

165

1381

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.46

0.76

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.17

0.76

1.6

2.08

2.55

mmol/24h

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

158

1401

1.12

0.75

1.4

0.40

0.38

g/l

0.32

110

995

(3009214) Lutropin [Units/volume] in Serum or Plasma

571

5361

1.06

0.75

1.2

11.04

12.11

u/l

1.19

484

4462

(3000570) Elastase.pancreatic [Mass/mass] in Stool

339

3124

1.08

0.75

1.4

1.3

306.30

303.01

ug/g

0.10

186

1631

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

369

3413

1.08

0.75

1.2

1.3

451.65

459.61

mg/l

0.09

356

3257

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

557

1.20

0.74

1.9

2.3

218.11

151.12

umol/l

0.45

281

(3033942) Copper [Moles/time] in 24 hour Urine

1.59

0.73

1.5

1.2

2.25

0.65

umol/24h

—

(40768806) Pleura Pathology biopsy report

501

0.79

0.73

1.9

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

236

1.31

0.72

1.5

1.4

45.48

45.54

0.00

150

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

1003

1.14

0.72

1.0

1.1

1.00

1.04

u/l

0.52

412

(3041354) Potassium [Moles/volume] in Venous blood

744

1.17

0.71

2.7

1.9

3.96

3.92

mmol/l

0.39

739

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.92

0.70

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

106

922

1.15

0.69

1.2

1.1

392.09

404.23

nmol/l

0.27

856

(3014891) Appearance of Pleural fluid

1.55

0.69

1.2

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.85

0.68

1.0

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.66

0.68

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

105

915

1.14

0.68

2.2

2.6

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.52

0.67

1.5

3.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

135

1.40

0.67

2.1

2.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.63

0.67

1.3

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

832

1.15

0.67

1.3

1.5

29553.57

47967.85

e6/l

0.32

567

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

668

0.83

0.66

1.1

1.0

11.91

10.11

u/ml

0.20

396

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

167

0.66

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

126

1114

1.13

0.66

1.8

1.9

18.90

19.72

nmol/l

0.55

121

1065

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.78

0.66

1.0

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

329

1.24

0.65

1.3

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

213

0.70

0.65

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

640

1.17

0.64

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.53

0.64

1.2

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

798

1.15

0.64

1.1

0.17

6.35

nmol/l

1.64

145

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

145

1.37

0.64

1.1

1.5

52.83

54.91

—

(44813793) Dust mix specific IgE antibody measurement

141

1259

1.12

0.63

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

240

2202

1.09

0.63

1.7

12710.34

8256.05

e6/l

0.86

185

1613

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

299

2769

1.08

0.62

1.3

1.5

31.00

16.32

iu/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

633

1.17

0.62

1.1

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

847

1.14

0.62

1.1

9.75

11.80

u/ml

0.15

143

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.49

0.62

2.1

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

102

0.59

0.62

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

1443

1.11

0.61

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.58

0.61

5.0

4.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

728

1.15

0.60

2.8

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

231

2122

1.09

0.60

1.4

1.5

0.57

0.60

g/l

0.27

175

1610

(3051611) Lipemic interference index of Serum or Plasma

110

972

1.13

0.60

2.8

2.7

—

(4062490) Immunoglobulin typing, IgG

156

1407

1.11

0.60

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

243

0.74

0.60

1.9

1.5

9.62

41.14

u/l

2.10

208

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

820

0.86

0.59

2.6

880.30

807.16

e6/l

0.53

800

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

461

1.19

0.59

1.0

1.1

323.75

441.37

ng/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1294

1.11

0.59

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1294

1.11

0.59

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

443

1.19

0.59

1.4

—

(3011288) Drugs identified in Urine by Screen method

595

5646

1.05

0.59

4.5

2.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

387

0.80

0.59

3.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1278

1.11

0.57

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1297

1.11

0.57

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.48

0.57

1.0

—

5.00

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

418

1.19

0.56

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

246

1.26

0.56

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1280

1.11

0.56

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1996

1.08

0.56

1.9

2.0

0.00

g/l

0.66

201

1821

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.48

0.56

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

193

1.29

0.56

2.0

1.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.45

0.55

1.1

—

(3028433) Virus identified in Specimen by Culture

364

1.20

0.55

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

447

1.18

0.55

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

512

1.17

0.54

1.1

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

764

1.14

0.54

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

764

1.14

0.54

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

764

1.14

0.54

1.3

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

271

2522

1.07

0.53

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

747

1.13

0.52

1.6

8.57

6.60

u/l

0.69

610

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1080

11114

0.97

0.52

2.7

2.9

35.12

40.54

u/ml

0.46

1050

10749

(3045788) Cell count panel - Pleural fluid

435

0.82

0.52

1.8

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

242

2244

1.08

0.52

2.5

2.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

650

0.86

0.52

3.8

3.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

141

1277

1.10

0.52

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

231

1.25

0.52

5.1

6.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

126

1136

1.11

0.51

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

1128

1.10

0.50

1.3

1.5

—

(40757373) Influenza virus identified in Isolate

170

1.29

0.50

1.7

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

461

4372

1.05

0.50

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

921

1.12

0.49

2.6

3.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

144

1.32

0.49

1.5

1.4

27.61

27.56

g/l

0.00

110

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

1130

1.10

0.49

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

503

5248

0.95

0.49

1.4

80.23

101.99

pmol/l

1.94

497

5112

(4094501) Cardiovascular stress test using bicycle ergometer

269

2513

1.07

0.48

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

407

1.18

0.48

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

1093

1.10

0.48

1.7

1.6

—

(3025577) Chromium [Mass/volume] in Blood

297

1.21

0.48

2.1

2.39

2.92

ug/l

0.41

259

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

898

0.89

0.48

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

110

1.36

0.47

2.1

1.3

38.47

24.92

0.82

100

(3035947) Staphylolysin Ab [Units/volume] in Serum

473

1.16

0.47

1.0

1.1

4.40

3.35

iu/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

644

6167

1.04

0.47

3.0

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

119

1.34

0.47

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

137

1249

1.09

0.46

1.1

1.0

0.73

1.40

u/ml

0.74

370

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

615

1.13

0.46

1.7

2.1

52.22

22.61

ug/l

0.41

605

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

629

6027

1.04

0.45

2.2

2.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.60

0.45

1.2

1.0

—

3.85

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

234

2184

1.07

0.45

1.8

2.0

38.41

38.91

g/l

0.61

211

1963

(3012494) Peanut IgE Ab [Units/volume] in Serum

560

1.14

0.44

1.1

0.23

2.19

u/ml

3.35

317

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

469

0.85

0.44

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

129

1177

1.09

0.44

1.7

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

221

2061

1.07

0.44

1.3

36.15

52.09

u/ml

0.46

152

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.37

0.43

1.0

1.1

30.96

36.30

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

183

1.25

0.43

1.0

0.06

0.36

u/ml

0.97

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

263

2468

1.06

0.43

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

921

0.90

0.43

2.5

0.20

0.23

e9/l

0.58

776

(3021788) Differential panel - Synovial fluid

189

1755

1.07

0.43

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

381

0.84

0.42

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.37

0.41

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

294

1.19

0.41

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

294

1.19

0.41

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

294

1.19

0.41

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

294

1.19

0.41

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10946.00

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.51

0.41

1.2

1.1

19.20

19.30

g/l

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate

105

953

1.10

0.41

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

358

3742

0.95

0.40

1.3

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.47

0.40

1.4

1.0

0.80

1.00

u/field

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

369

1.16

0.40

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.42

0.39

71.8

13.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

159

1.25

0.39

1.7

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.39

0.0

1.6

—

1864.08

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

2.40

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.36

0.38

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

211

1978

1.06

0.38

1.9

2.0

0.00

g/l

-0.00

199

1818

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.38

0.38

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

530

5088

1.04

0.38

1.3

3.24

3.34

ug/l

0.21

473

4670

(3011841) English Walnut IgE Ab [Units/volume] in Serum

187

1.23

0.37

1.0

0.02

0.81

u/ml

0.69

135

(3001729) Color of Synovial fluid

1.32

0.37

1.2

1.7

—

(3000494) Fungus identified in Specimen by Culture

1360

13850

0.98

0.37

1.4

—

(3023410) Appearance of Cerebral spinal fluid

135

1449

0.93

0.37

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

298

1.17

0.36

3.6

4.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

289

1.17

0.36

1.3

142.85

108.21

nmol/l

0.44

225

(3018001) Oat IgE Ab [Units/volume] in Serum

152

1.25

0.36

1.1

1.0

1.00

0.97

u/ml

0.01

(3044242) Glucose [Moles/volume] in Arterial blood

327

1.16

0.35

1.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

115

1058

1.08

0.35

1.3

2.08

1.91

mmol/l

0.63

110

986

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.42

0.35

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.42

0.35

1.7

7.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.63

0.35

1.6

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

393

1.14

0.35

3.0

2.9

27.29

27.84

umol/l

0.14

305

(3045142) Bone marrow Pathology biopsy report

791

1.10

0.35

1.4

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

677

1.10

0.34

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

201

1890

1.06

0.34

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

201

1891

1.06

0.34

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

346

3303

1.04

0.34

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

414

1.13

0.33

1.1

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.31

0.33

1.0

1.1

—

24.71

—

(3025130) Human papilloma virus identified in Specimen

397

4111

0.96

0.33

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

165

0.78

0.32

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

452

0.88

0.31

2.0

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

250

0.84

0.30

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.32

0.30

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9192

91156

1.01

0.30

3.0

2.7

38.39

34.41

u/l

5.49

8756

86930

(3016879) Cocaine [Presence] in Urine

752

7302

1.03

0.30

2.8

2.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

305

1.14

0.29

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

439

0.88

0.29

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.29

0.29

1.7

2.0

15.64

14.75

ml/dl

0.71

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

107

0.74

0.29

6.9

6.3

0.47

0.36

umol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

162

0.80

0.29

1.1

2.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

166

1.20

0.29

1.3

1.4

16.11

13.39

g/l

0.82

129

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

391

1.12

0.28

3.2

2.8

67.18

89.68

ng/l

0.65

179

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

148

1.21

0.28

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

185

1.19

0.28

1.0

0.03

0.31

u/ml

0.86

139

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

258

0.85

0.28

1.6

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

258

0.85

0.28

1.6

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

946

0.93

0.28

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

176

1.19

0.28

1.3

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

821

7994

1.02

0.27

1.3

213.33

232.17

miu/ml

0.85

389

4100

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.25

0.27

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.25

0.27

1.1

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

157

1481

1.06

0.27

1.3

1.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

242

1.15

0.26

1.0

0.03

0.15

u/ml

1.09

132

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

1036

1.07

0.26

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

160

0.81

0.26

2.0

1.6

0.48

2.15

mg/l

—

102

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

963

9402

1.02

0.26

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

1210

0.94

0.26

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

633

0.91

0.26

1.4

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

110

1028

1.07

0.26

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.26

0.25

1.2

1.3

1.93

2.14

mmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

232

2216

1.04

0.25

1.3

1.20

1.42

nmol/l

2.32

201

1908

(3041672) Baker's yeast Ab [Presence] in Serum

1.23

0.25

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.23

0.25

1.7

1.6

243.11

303.59

umol/24h

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

702

1.08

0.24

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

123

1.22

0.24

1.9

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

367

1.11

0.24

1.6

1.7

9.11

8.41

ug/l

0.54

367

(40768795) Lymph node Pathology biopsy report

117

1099

1.06

0.24

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

359

0.89

0.24

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

105

1.23

0.24

6.5

4.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

501

4863

1.03

0.23

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

533

5444

0.97

0.23

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

977

0.94

0.23

1.2

254.38

165.31

titre

0.39

179

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

928

1.06

0.22

1.6

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.25

0.22

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1001

10145

0.98

0.22

2.3

23.89

22.18

au/ml

0.20

972

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

351

1.11

0.22

1.8

2.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

572

1.08

0.21

3.1

2.7

47.20

44.28

0.62

346

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

2.2

—

17.00

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.0

—

295.00

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

6.42

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

(3019977) pH of Arterial blood

407

0.91

0.21

1.6

2.7

7.45

7.43

1.27

112

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

550

5357

1.02

0.21

1.9

2.1

39.20

39.60

u/l

0.19

506

4950

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

11.13

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1003

0.94

0.20

5.4

6.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

1.87

0.76

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

0.93

2.02

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

1.13

2.38

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

0.55

2.77

mg/l

—

101

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

1.33

1.83

mg/l

—

102

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

1.20

2.46

mg/l

—

101

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

1.25

1.99

mg/l

—

109

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

3.79

4.18

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

155

0.84

0.20

2.0

1.6

0.27

1.03

mg/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

176

0.85

0.20

1.7

1.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.22

0.20

1.2

1.3

24.50

606.64

u/l

—

(3050794) Legionella sp Ab [Presence] in Serum

1.25

0.20

1.1

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.20

0.19

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

136

1.17

0.19

1.3

1.1

—

(4035726) Immunohistochemistry procedure

977

9586

1.02

0.19

1.4

—

(4212803) Bone marrow aspirate examination

1.13

0.18

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

119

1242

0.95

0.18

1.1

1.0

0.57

2.81

u/ml

1.83

275

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

558

1.07

0.18

1.6

—

(4200892) Spirometry reversibility

800

8103

0.98

0.18

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.20

0.18

1.3

1.8

0.33

0.22

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

936

0.95

0.18

2.5

563.71

506.35

e6/l

0.59

772

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

1396

1.04

0.18

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

546

0.93

0.17

1.8

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

309

1.10

0.17

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

1017

1.05

0.17

1.4

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.20

0.17

1.6

3.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.20

0.17

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.75

0.17

1.2

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.74

0.17

1.0

0.08

0.07

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

233

1.11

0.16

1.5

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

375

3651

1.02

0.16

1.2

1.3

48.75

42.56

u/ml

0.28

394

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

297

0.91

0.16

1.2

0.47

0.35

nmol/l

0.38

202

(3035933) Granulocytes/100 leukocytes in Blood

455

1.07

0.16

2.7

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

452

4413

1.02

0.16

1.3

1.4

21.42

25.26

u/l

2.11

380

3635

(3023420) DNA double strand Ab [Units/volume] in Serum

183

1764

1.03

0.16

2.1

1.6

33.19

iu/ml

0.00

(3009677) Dengue virus Ab [Presence] in Serum

1.11

0.16

1.0

1.2

—

(3051339) Copper [Moles/volume] in Blood

0.79

0.15

1.5

1.4

16.87

17.33

umol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

327

0.91

0.15

1.4

2.1

8.71

2.34

ug/l

0.40

201

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

485

1.07

0.15

1.3

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.75

0.15

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

398

1.08

0.15

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

292

1.09

0.15

1.2

1.7

—

500.20

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1889

18657

1.01

0.15

2.3

2.5

2.43

mmol/l

0.26

1651

16292

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

130

1.15

0.15

1.0

1.1

46.90

43.32

mg/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

486

1.07

0.15

1.3

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

632

1.06

0.14

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.79

0.14

1.0

1.5

—

(3002256) Pathology report gross observation

1716

16947

1.01

0.14

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

377

0.92

0.14

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

377

0.92

0.14

1.5

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

459

0.93

0.14

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

117

1121

1.04

0.14

2.3

2.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

740

1.05

0.14

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

438

0.93

0.14

1.0

42.70

41.87

ng/l

0.05

314

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

188

1.11

0.14

1.3

1.8

340002.32

361398.67

nmol/l

0.02

158

(3011412) CD3 cells [#/volume] in Blood

121

1251

0.96

0.14

2.3

2.4

1.39

1.30

e9/l

0.49

102

1099

(3020393) Adenovirus Ag [Presence] in Stool

0.81

0.13

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

478

0.94

0.13

1.8

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

810

7969

1.01

0.13

2.7

1.9

—

(3010503) CD19 cells [#/volume] in Blood

722

0.95

0.13

2.4

2.6

0.12

0.35

e9/l

1.50

711

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

0.85

0.13

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

109

0.82

0.13

1.0

1.3

—

(3025941) Bacteria identified in Stool by Culture

892

8786

1.01

0.12

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

247

1.09

0.12

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

497

0.94

0.12

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

113

1.15

0.12

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

137

0.87

0.12

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

435

0.94

0.12

1.0

711.47

761.38

ng/l

0.30

313

(3049717) Cytology report of Urine Cyto stain

201

1953

1.03

0.12

2.0

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

383

0.94

0.11

1.5

1.9

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

200

1.10

0.11

1.0

0.04

0.03

u/ml

0.04

106

(3037692) Legionella sp identified in Specimen by Organism specific culture

287

1.08

0.11

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

546

0.95

0.11

1.6

1.4

1658.91

3206.86

e6/l

1.07

385

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

941

0.96

0.11

2.1

—

(3044941) Cell count panel - Synovial fluid

146

1414

1.03

0.11

1.4

—

(3028300) Cannabinoids [Presence] in Urine

815

8033

1.01

0.11

2.8

1.9

—

(3022475) Manganese [Moles/volume] in Blood

114

1.14

0.11

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

167

1623

1.03

0.10

1.1

—

30.10

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

280

2739

1.02

0.10

1.1

13.23

10.95

au/ml

0.14

198

(40768804) Tissue Pathology biopsy report

5669

56641

1.00

0.09

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

155

0.90

0.09

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.08

0.09

1.0

1.1

29.56

13.32

mg/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

146

1419

1.03

0.09

1.2

1.1

199.49

207.00

mg/l

0.44

130

1240

(1002224) Polysomnography panel

616

6072

1.01

0.09

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.11

0.09

1.2

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

113

0.88

0.09

2.4

2.0

3.85

3.33

mg/l

—

108

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

242

1.07

0.08

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

281

1.06

0.08

1.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2158

21607

0.99

0.08

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

104

1065

0.97

0.08

1.2

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

703

1.03

0.08

1.3

1.2

72.55

83.07

u/l

1.01

628

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

233

1.07

0.08

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

811

8015

1.01

0.08

2.7

1.9

—

(3002619) Bacteria identified in Specimen by Culture

245

0.94

0.08

1.1

1.2

—

(40758558) Short blood count panel - Blood

3109

31085

1.00

0.07

5.6

6.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.83

0.07

1.7

2.2

59.50

44.46

umol/l

—

(40758358) Immune stain study

0.83

0.07

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.86

0.07

1.1

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.85

0.07

1.0

1.4

—

(3027944) Amphetamines [Presence] in Urine

798

7894

1.01

0.07

2.6

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

254

0.94

0.07

1.8

2.1

395.00

873.57

e6/l

1.51

159

(3024891) Influenza virus A+B Ag [Presence] in Specimen

365

3677

0.99

0.07

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

904

1.03

0.06

1.4

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.84

0.06

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

173

1695

1.02

0.06

3.4

4.4

93.65

126.73

u/ml

0.39

551

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

934

9363

0.99

0.06

1.2

1.3

54.07

42.63

au/ml

0.51

433

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

0.86

0.06

1.1

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

243

0.94

0.06

1.0

1.2

—

(40768443) Skin Pathology biopsy report

524

5178

1.01

0.06

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

293

0.95

0.06

1.0

0.01

0.04

u/ml

0.65

172

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

285

1.05

0.06

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

151

0.92

0.05

2.6

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

151

0.92

0.05

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

323

0.96

0.05

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

323

0.96

0.05

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

323

0.96

0.05

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

197

1.06

0.05

2.3

2.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

343

0.96

0.05

1.1

0.06

0.80

u/ml

1.58

234

(3044007) Cell count panel - Peritoneal fluid

207

1.06

0.05

1.8

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

160

0.93

0.04

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

119

1205

0.98

0.04

2.1

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

281

0.96

0.04

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

149

1465

1.01

0.04

1.7

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

662

0.98

0.04

1.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

148

1456

1.01

0.04

1.2

1.1

33.85

36.34

mg/l

0.35

122

1215

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

431

0.97

0.04

1.0

1191.58

332.62

ng/l

0.51

316

(3052592) Norovirus Ag [Presence] in Stool

169

0.94

0.03

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

581

0.98

0.03

1.8

1.4

32.32

35.61

g/l

0.94

538

(3030313) Adrenal Ab [Titer] in Serum

229

1.04

0.03

1.2

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

576

5766

1.00

0.03

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

500

0.98

0.03

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

1.06

0.03

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

288

2851

1.01

0.03

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

282

2827

0.99

0.02

1.1

4.06

2.66

u/ml

0.55

125

1541

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

127

1252

1.01

0.02

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

228

0.96

0.02

1.6

1.9

3134.38

16080.32

e6/l

0.70

105

(3000060) B lymphocytes [#/volume] in Blood

438

0.98

0.02

2.0

201.11

172.60

e6/l

0.23

235

(1175426) CD3 cells/100 lymphocytes in Blood

101

1018

0.99

0.02

2.1

77.00

75.20

0.89

980

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

164

1621

1.01

0.02

1.1

—

62.64

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

915

9139

1.00

0.02

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

932

9307

1.00

0.02

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

142

1.05

0.02

2.1

0.87

0.86

u/field

0.01

142

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

509

1.02

0.02

1.3

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

207

0.96

0.02

1.0

0.16

0.12

u/ml

—

109

(3027231) Wheat IgE Ab [Units/volume] in Serum

397

0.98

0.02

1.0

0.29

0.85

u/ml

1.74

323

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

689

1.01

0.01

1.3

1.2

14.94

19.55

u/l

0.98

599

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

116

1147

1.01

0.01

1.9

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

156

0.96

0.01

1.1

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

485

0.99

0.01

1.6

1.4

162938.45

45486.43

e6/l

0.50

263

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

338

3360

1.00

0.00

2.0

2.2

10.59

10.20

mg/l

0.39

316

3156

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1093

10884

1.00

0.00

2.5

2.3

43.04

36.40

u/l

0.70

907

9310

(3051651) Icteric interference index of Serum or Plasma

585

1.00

0.00

3.3

3.1

—

(3017569) Oxygen content in Arterial blood

297

1.01

0.00

1.9

2.0

—

(3033799) Differential panel - Peritoneal fluid

225

1.02

0.00

1.6

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

199

1.00

0.00

1.4

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

194

1.03

0.00

1.4

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

165

1.03

0.00

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

154

1.04

0.00

2.1

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

154

1.04

0.00

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

145

1.03

0.00

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

119

1.00

0.00

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

116

1.03

0.00

1.4

1.5

15.92

21.08

0.53

101

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.05

0.00

1.1

1.64

219.49

ug/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

124

0.96

0.00

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

115

1147

1.00

0.00

1.1

9.82

8.10

iu/ml

0.29

327

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

301

0.99

0.00

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

151

1500

1.00

0.00

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

303

0.99

0.00

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

153

0.98

0.00

1.1

1.0

0.74

0.35

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

333

0.99

0.00

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

230

1.00

0.00

1.1

1.3

36.84

38.66

g/l

0.20

114

(3035880) pH of Pleural fluid

234

0.98

0.00

1.5

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

232

0.99

0.00

1.1

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.4

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.96

0.00

1.2

2.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.09

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.96

-0.00

1.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.95

-0.00

1.0

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.89

-0.00

1.0

1.1

32.17

53.14

u/l

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

2.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_PREEC_OR_FETGRO and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_PREEC_OR_FETGRO	0.837 [0.72, 0.97]	0.017
Birth year	0.999 [0.99, 1.01]	0.864

During the follow-up period (1.1.1998 — 31.12.2019), 408 out of 58076 females with O15_PREEC_OR_FETGRO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_PREEC_OR_FETGRO.

N-year risk	Females	Males
1	0.074%	No data
5	0.497%	No data
10	1.248%	No data
15	2.567%	No data
20	4.479%	No data

Relationships between endpoints

↥

Index endpoint: O15_PREEC_OR_FETGRO – Pre-eclampsia or poor fetal growth

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-eclampsia or poor fetal growth

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints